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Abstract 
 
Xanthones are a class of secondary metabolites widely found in many natural 
organisms. Their diverse pharmacological activities have elicited much interest, 
particularly in their synthesis. This class of compound contains the basic dibenzo-γ-
pyrone ring system. The dissertation involves the use of a ceric ammonium nitrate 
(CAN) mediated oxidation reaction as a key step to form a range of xanthone and 
dione compounds, which include 2,3-dimethoxy-9H-xanthen-9-one, 12a-methoxy-
5H-benzo[c]xanthenes-5,7(12aH)-dione and the unexpected spiro compound 5-
chloro-2',5'-dimethoxy-3H-spiro(benzofuran-2,1'-cyclohexa[2,5]diene)-3,4'-dione.  
 
The synthesis of 2,3-dimethoxy-9H-xanthen-9-one started with the preparation of (2-
(benzyloxy)-5-chlorophenyl)(2,4,5-trimethoxyphenyl)methanone from benzyl-2-
(benzyloxy)benzoate and 1-bromo-2,4,5-trimethoxybenzene. This was followed by 
deprotection to afford hydroxyphenyl(2,4,5-trimethoxyphenyl)methanone. CAN was 
then utilized to execute the ring closure thus forming the xanthone nucleus in 91% 
yield. Using similar methodology 12a-methoxy-5H-benzo[c]xanthenes-5,7(12aH)-
dione was afforded from CAN mediated oxidation reaction of (1,4-
dimethoxynaphthalene-2-yl)2-hydroxyphenyl methanone in 72% yield. Having 
successfully produced xanthones and diones using simple systems, we then decided 
to determine how generalized the synthetic route is. The addition of halogens is 
believed to be important as they add to the biological activity by increasing the 
binding capacity, especially against malaria. For example in one transformation we 
prepared (5-chloro-2-hydroxyphenyl)(2,4,5-trimethoxyphenyl)methanone by similar 
methodology used for the preparation of hydroxyphenyl(2,4,5-
trimethoxyphenyl)methanone. CAN oxidation of this precursor lead to the isolation of 
three products. The first two were the expected 7-chloro-2,3-dimethoxy-9H-
xanthene-9-one and 7-chloro-3,4a-dimethoxy-2H-xanthene-2,9(4aH)-dione products 
while the third unexpected product was the spiro compound 5-chloro-2’,5’-
dimethoxy-3H-spiro(benzofuran-2,1'-cyclohexa[2,5]diene])-3,4-dione, the structure of  
which was confirmed using x-ray crystallography.  
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1 Chapter 1: Introduction and Aims 
 
In nature there are many oxygenated heterocycles which play an important role as 
pharmacologically active compounds. One such class of these oxygenated 
heterocycles is the xanthones.  Xanthones are known to be secondary metabolites 
that are found to occur in higher plant families, fungi and lichen1. Xanthones are 
typified by the presence of a 9-xanthenone or dibenzo-γ-pyrone ring system, 12, 3. To 
date approximately 200 different naturally occurring xanthones have been described. 
The tricyclic scaffold present in these xanthones as well as the variety and position 
of different substituents contribute to their pharmacological activities.3, 4 
 
 
 
1.1 Naturally occurring xanthones 
 
The xanthone family displays an extensive range of biological activity which includes 
anti-fungal and anti-bacterial activities, anti-tumour activity as well as antiviral 
activity2. Xanthones can be classed into five major groups, those being simple 
oxygenated xanthones, xanthone glycosides, prenylated xanthones, 
xanthonolignoids and miscellaneous xanthones 3, 5. Each of these classes will be 
discussed in more detail below. 
 
1.1.1 Simple oxygenated xanthones 
 
Simple oxygenated xanthones represent a diverse class of xanthones which range 
from mono-oxygenated to hexa-oxygenated compounds. This class of xanthones 
arises as a result of their degree of oxygenation2. Simple examples of this class are 
euxanthone 2 and norathyriol 34. Euxanthone 2, which has been isolated from the 
roots of the medicinal herb Polygala caudata has been shown to be a potent  
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neuropharmacologically active compound6. Norathyriol 3, a xanthone aglycone has 
been isolated from the aerial parts of Tripterospermum lanceolactum and exhibits 
inhibition of phorbol ester-induced respiratory burst which arises from the direct 
suppression of the PKC activity7.  
 
 
 
1.1.2 Glycoside xanthones 
 
Glycoside xanthones are further divided into two sub-groups depending on the 
position and nature of the glycosidic linkage. The two sub-groups are O-glycoside 
xanthones and C-glycoside xanthones. C-glycosides are known to be resistant to 
acid and enzymatic hydrolysis. Examples of this are swertifrancheside 4, which 
shows anti-HIV activity, and mangiferin 5, which exhibits an immunoprotective role 
by mediating the inhibition of reactive intermediate-induced oxidative stress in 
lymphocytes8. They have been isolated from Swertia franchetiana and Mangifera 
indica respectively.9 
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1.1.3 Prenylated xanthones 
 
This class of xanthones constitutes the major group of naturally occurring xanthones. 
There are a number of prenylated xanthones known both synthetic and natural. 
Examples of this class of xanthones are α-mangostin 6, which induces apoptosis of 
human leukemia cells 10, and jacareubin 7 which inhibited the mycelial growth of the 
brown rot fungus Postia placenta11. These xanthones were isolated from the 
pericarps of mangosteen (Garcinia mangostana Linn.) and the heartwood of 
Calophyllum neo-ebudicum respectively. 
 
 
 
1.1.4 Xanthonolignoids 
 
The xanthonolignoid class of xanthones are compounds which consist of a 
phenylpropane skeleton which is linked to an ortho-dihydroxyxanthone via a dioxane 
ring. This is formed by radical oxidative coupling. These compounds are considered 
to be very promising due to their biological activities associated with both the 
xanthone and the benzodioxane moiety12. Examples of these xanthonolignoids 
include kielcorin 8 and hipericorin 9, which have been isolated from Kielmeyera 
rubriflora and Hypericum mysorense respectively13. 
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1.1.5 Chlorinated xanthones 
 
The final class of xanthone compounds acquired its name due to the unusual 
substitutions that the xanthones possess. These compounds were isolated from a 
variety of plant sources. Examples of these compounds include 1,3,6-tri-O-
methylarthotheline 10 and 4,5-dichloro-6-O-methylnorlichexanthone 11 and are 
generally called the “chlorine compounds”14, 15. 
 
 
 
1.2 Biological Activity 
 
To date there have been numerous reports appearing in the literature concerning the 
pharmacological properties of both naturally occurring and synthetic xanthones. 
These properties range from anti-bacterial, anti-oxidant, anti-viral, anti-malarial as 
well as anti-tumour activity16, 17. 
 
1.2.1 Anti-viral activity 
 
In recent years, naturally occurring xanthones have shown activity against a number 
of human viruses. One such virus of great interest and importance is the human 
immunodeficiency virus (HIV). The life cycle of the virus is dependent on three 
essential HIV enzymes. The first of these enzymes is reverse transcriptase which is 
responsible for viral replication. The second is HIV protease whose function is the 
processing of viral polyproteins into functional enzymes and structural proteins, 
which enable the maturation and increase the infectivity of the virion particles. The 
third enzyme is HIV integrase whose function is to mediate HIV integration into the 
host chromosome. Therefore, much research is currently being focused into the 
development of inhibitors of these enzymes18. These xanthones are of importance as 
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they not only act against HIV but they are also known to act against fungal infections 
which occur in immune-compromised patients such as HIV patients19. 
 
Swertifrancheside, was the first isolated flavonexanthone from Swertia franchetiana 
in 1994 by Wang et al.9. This compound was found to be a moderately potent 
inhibitor of DNA polymerase activity of HIV-1 reverse transcriptase. Wang et al. 
determined that this compound 4 displayed inhibitory activity of 99.8% at 200 µg/mL 
(ED50= 30.9 µg/mL) against HIV-1 reverse transcriptase while the dimer xanthone 
swertpunicoside 12 displayed inhibitory activity at ED50= 3.0 µg/mL. Furthermore, 
this study also showed that compound 4 displayed no cytotoxicity and anti-malarial 
activity. 
 
 
 
It is known that reverse transcriptase is essential for early proviral DNA synthesis. 
Therefore, inhibition of the reverse transcriptase catalysed polymerisation ultimately 
leads to inhibition of virus replication. In a study conducted by Pengsuparp and co-
workers, data were collected which suggested that compound 4 binds to DNA thus 
mediating inhibition. Furthermore, the data suggest that the aromaticity present 
within the xanthone scaffold leads to the binding of 4 to DNA. However, it was also 
noted that although compound 4 showed activity against reverse transcriptase, the 
activity was negligible when compared to that of azidothymidine (AZT), a known 
compound for HIV treatment.20  
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A study conducted by Groweiss and co-workers in 2000 resulted in the isolation of 
macluraxanthone B 13 and macluraxanthone C 14 from Maclura tinctoria21.  
 
 
 
Of all the compounds subjected to anti-HIV screening in this study, compounds 13 
and 14 were found to display the best potential at an EC50 value of 1.1-2 µg/mL. It 
appears that the catechol functionality of compounds 13 and 14 offers an 
enhancement in their HIV-inhibitory activity. Furthermore, these compounds also 
exhibited high toxicity toward CEM-SS host cells with IC50 levels of 2.2-17 µg/mL.  
 
A recent study by Magadula showed the isolation and structural elucidation of a new 
novel isoprenylated xathone, commonly referred to as garceduxanthone 1522. This 
new xanthone was isolated from the root bark of Garcinia edulis, a plant species 
found in tropical Africa. Solvent-solvent extraction of the ethanol extract followed by 
a rigorous purification yielded three pentacyclic triterpenoids as well as the novel 
xanthone 15 and a known xathone, forbexanthone 16.  
 
 
 
The results from this study found that the crude extract exhibited mild anti-HIV-1PR 
activity with IC50 value of 51.7 µg/mL. Once purified, the new xanthone 15 exhibits 
strong anti-HIV-1PR activity with IC50 value 11.3 µg/ml while the known xanthone 16 
was inactive.  
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1.2.2 Anti-malarial activity 
 
Malaria is believed to have plagued the human race through antiquity. It has 
therefore become of utmost importance to develop a long lasting vaccine to try and 
eradicate this disease. Xanthones have been shown to display potent biological 
activity against Plasmodium parasites, the protozoan parasite responsible for the 
disease 23. Due to the emergence of chloroquine drug resistant strains of 
Plasmodium falciparum it has become important for the discovery and development 
of mechanistically novel of anti-malarial compounds24.  
 
The digestive food vacuole is an acidic proteolytic compartment and is the site of 
haemoglobin digestion. It therefore could be regarded as the parasite’s Achilles 
heel24. Digestion of the haemoglobin leads to the release of unbounded haem which 
is highly reactive as well as toxic to the malaria parasite. The breakdown of 
haemoglobin serves to provide amino acids which aid the growth of the parasite the 
liberated haem is detoxified by the parasite to form hemozoin which is a non-toxic 
substance to the parasite, due to its insolubility. Therefore, it seems a feasible 
approach to target the digestive vacuole of the parasite by forming a soluble drug-
haem complex. This will therefore halt hemozoin formation and aggregation and lead 
to an increase in the toxic haem which will eventually result in the rupture of the 
parasites digestive vacuole25.   
 
Ignatushchenko and co-workers studied the effect that a highly substituted xanthone 
X5 17 has on the digestive vacuole of the parasite24. In vitro studies confirmed that 
X5 did in fact form soluble complexes with the haem monomers and oligomers 
tested and interfered with the formation of hemozoin26. 
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Riscoe and co-workers conducted a study in which they synthesized and tested the 
cytotoxicity of the xanthone 3,6-bis(ω-N,N-diethylaminoamyloxy)-4,5-
difluoroxanthone (F2C5)1825.  
 
 
 
 
 
F2C5 was tested against multidrug resistant malaria strains W2 and D6 of P. 
falciparum and IC50 values of 150 nM and 93 nM were observed for the respective 
strains. Chloroquine shows activity against W2 and D6 with IC50 values of 290 nm 
and 7.8 nm respectively. The value of F2C5 against W2 is comparable to 
chloroquine, however, the IC50 value for D6 is considerably lower25. It is believed that 
the carbonyl bridge in the xanthone tricyclic scaffold co-ordinates to the haem 19 iron 
atom. The aromatic rings on either side of the carbonyl bridge undergo π-π stacking 
with co-planar aromatic rings of the haem23. The presence of protonatable amine 
chains of five carbon length increases the reactivity of 18 due to the ionic interaction 
with haem propionate groups. These basic protonatable amine groups also assist in 
the drug being directed to the parasite’s acidic vacuole23. Incorporation of halogens, 
such as highly electronegative fluorine, in positions 4 and 5 of the xanthone scaffold 
is believed to enhance binding to the haem. This is due to the increased partial 
positive charge on these positions which will lead to enhanced electrostatic 
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interaction with the negative haem ring27. This stronger interaction will also result in 
the stabilisation of the drug-haem complex which will prevent further hemozoin 
formation28. 
 
The position of the hydroxyl groups is believed to be of importance as observed in a 
study conducted by Hay and co-workers29. Their study tested 
demethylcalabaxanthone 20 and calowaitesixanthone 21 against chloroquine-
resistant strains of the malaria parasite. Xanthones 20 and 21 showed activity with 
an IC50 value of 0.9 µg/ml and IC50 value 1.0 µg/ml respectively. They concluded that 
the increased activity was also due to either the presence of a 1,1-dimethylallyl chain 
or an additional pyran ring. 
 
 
 
Therefore, all the research being conducted confirms that the xanthone scaffold is 
pivotal in the activity of a haem poison such as F2C5. This is due to the xanthone 
scaffold being positioned in an orientation where all its structural features maximises 
its inhibitory potential. 
 
1.2.3 Anti-tumour activity 
 
Xanthones are known to possess a range of biological activity as mentioned earlier. 
However, among these, the in vitro inhibitory activity on the growth of a wide range 
of different tumour cell lines proves to be quite remarkable4. 
 
Psorospermin 22 is a naturally occurring xanthone isolated from the dried roots of 
Psorospermun febrifugum, which is indigenous to tropical Africa. Kupchan and co-
workers conducted the isolation studies as well as cytotoxic assays on the isolated 
extract30. In their study they managed to elucidate the structure of 22, however, the 
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absolute stereochemistry of the dihydrofuran ring and epoxide moiety was not 
assigned. 
 
 
 
The initial study also included the first biological activity studies of 22. The extract of 
P. febrifugum was found to exhibit significant activity both in vivo and in vitro. 
Biological activity was shown in vivo against P-338 lymphocytic leukemia at doses 
ranging from 8 to 0.1mg/kg and in vitro against a human epidermoid carcinoma at 
ED50 = 0.1 µg/ml. 
 
Years later, Cassady and co-workers assigned the absolute configuration of both the 
dihydrofuran ring and epoxide moiety. They further attempted to synthesized three 
psorospermin derivatives which showed activity considerably lower than their parent 
compound, psorospermin31. This therefore proved the importance that the 
dihydrofuran ring and epoxide moiety is essential for biological activity. In the same 
year, they reported another study toward the total synthesis of 22. However, their 
study resulted in the epimer 23 of 22 being prepared, which was further confirmation 
of the absolute stereochemistry earlier assigned32.  
 
 
 
In recent years, psorospermin remains of interest and its first total synthesis was 
reported in 2005 by Schwaebe and co-workers33. Their synthetic route started with 
the classical Grover, Shah and Shah reaction (see section 1.4.1.1) to achieve the 
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hydroxyxathone, and utilised a zipper-type reaction similar to that used in the 
synthesis attempted by Cassady and co-workers.  
 
In 2003, Hurley et al. conducted a study on 22 and its possible mode of biological 
action34. It was shown that the xanthone backbone is pivotal for 22 to be biologically 
active. Psorospermin is believed to intercalate DNA in a parallel fashion resulting in 
the tricyclic xanthone chromophore being adjacent to DNA base pairs. This places 
the epoxide moiety in a position in which electrophilic attack of the epoxide by N7 of 
guanine, located at the 3’ side of DNA intercalation, to take place. This results in a 
lesion which is cationic and may depurinate inside cells. 
 
Topoisomerase II is an enzyme which acts as a catalyst and induces changes in the 
topology of DNA. It plays several important roles in DNA metabolism and 
chromosome structure and acts via a mechanism that involves transient double-
strand breakages and rejoining of phosphodiester bonds. This enzyme is therefore 
the primary target for a number of potent anti-cancer drugs35. Anti-cancer drugs such 
as psorospermin are known as topoisomerase poisons and interact with the 
topoisomerase II-DNA complex. These interactions interferes with the breaking and 
rejoining reaction of the enzyme and traps the reaction intermediate, the covalently 
bonded topoisomerase II-DNA complex36. The efficacy of the drug is dependent on 
how well it binds to the reaction intermediate and the duration of this interaction as 
loss of this binding will result in the continuation of enzymatic activity. Therefore, 
compounds which are able to irreversibly bind to the reaction intermediate are likely 
to show potent cytotoxicity toward cancer cells37. 
 
The first known vascular-disrupting agent to enter phase III trials is 5,5-
dimethylxanthenone-4-acetic acid 24, also known as ASA404 or DMXAA. This drug 
is known to disrupt the functioning of tumour blood vessels by inducing apoptosis in 
the tumour cells, which in turn leads to vascular collapse as well as haemorrhagic 
necrosis. This entire process results in the tumour being deprived of oxygen in a 
process called tumour hypoxia38. Yang and Denny illustrated a new short synthesis 
of 24 and use of DMXAA in combination with docetaxel has been suggested to show 
increased activity in advanced prostate cancer38, 39.  
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Research has also been conducted into the possible use of xanthones as inhibitors 
of Epstein-Barr virus (EBV) by Ito and co-workers. These xanthones will ultimately 
function as anti-tumour promoters. In their study, 20 xanthones were tested and it 
was found that activity was observed for most of the xanthones tested.  The study 
showed that the presence of the 1,3-dihydroxy-2,4-diprenylxanthone unit was 
important for more potent inhibitory activity while the essential component for the 
activity of these xanthones was the presence of the prenyl group at C-2 and C-4 
position of the 1,3-dihydroxyxanthone nucleus. Examples of such compounds are 
dulxanthone-B 25 and latisxanthone-C 2640. 
 
25 26
O
O
O
OH
OH
OHO
O
HO
OH
OH
O
 
 
Recently, Cho et al. conducted a study which involved the synthesis of a number of 
xanthone derivatives. These compounds were then tested against various cancer 
cell lines35. Their study prepared 12 benzoxanthone derivatives, with most 
compounds showing effective cancer cell growth inhibition against cancer cell lines 
HT29 and DU145 which are human intestinal epithelial cells and human prostate 
carcinoma cell lines respectively. Compounds showed activity on topoisomerase I 
and II, with some showing comparable activity to camptothecin. Examples of the 
compounds tested in this study are 27 and 28. 
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1.3 Biosynthesis 
 
Compounds with the benzophenone skeleton are suggested to be biosynthesized by 
two types of routes, namely the acetate-polyketide route and the mixed shikimate-
polyketide pathway. The acetate-polyketide route is believed to occur in fungi while 
the shikimate-polyketide route in higher plants2. The mechanisms for both pathways 
have yet to be elucidated, however mechanisms for these have been speculated 
over the years. 
 
1.3.1 Acetate polyketide route 
 
Birch et al. used radioactive carbon labelling to determine the biosynthetic pathway 
of ravenelin 29, a naturally occurring xanthone isolated from two species in the 
fungal family Helminthosporium41. Their study confirmed that ravenelin is produced 
completely from polyketides. The polyketide pathway is similar to the pathway in 
which fatty acids are synthesized. The cyclisation of the polyketide produces an 
anthraquinone intermediate 30 which rearranges to produce the xanthone as shown 
in Scheme 1. 
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Scheme 1 
 
Their study also confirmed that oxygenated benzophenone intermediate 31 is 
derived from polyketides and is the intermediate in the biosynthesis of ravenelin. The 
benzophenone intermediate 31 is acetate-derived and is formed from two distinct 
units, these units being derived from acetate and malonate. An alternative route to 
the benzophenone intermediate 31 is via anthrone and anthraquinone intermediates 
which are themselves derived from a single polyketide chain. 
 
An example using the anthrone or anthraquinone intermediate is the biosynthesis of 
the benzophenone sulochrin 32.  
 
 
 
1.3.2 Shikimate-polyketide route 
 
The generally accepted idea in this biosynthetic pathway is that one of the aromatic 
rings with the carbonyl group is derived from the shikimate acid pathway while the 
other aromatic ring arises from the acetate-polyketide pathway.  These two moieties 
then condense to form the benzophenone intermediate which in turn reacts 
intramolecularly to produce the xanthone product2.  
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Carpenter and co-workers proposed that the benzophenone intermediate 33 is 
formed by condensation of phenol 34, which is acetate-derived with benzoic acid 35, 
which is shikimate-derived42. The benzophenone intermediate 33 can then undergo 
intramolecular reactions to afford the xanthones 36 and 37 (Scheme 2). 
 
 
 
Scheme 2 
 
1.4 Synthetic strategies towards xanthones 
 
In recent years there has been an increase in the interest in xanthone synthesis. 
This is partly due to the diverse pharmacological activities which xanthones exhibit. 
Another reason for the increase in xanthone research is in the medicinal chemistry 
industry where these compounds have been shown to bind to different classes of 
receptors43. Not only are xanthones of interest due to their biological activity, the fact 
that they possess photochemical properties allows for their use in other areas of 
medicinal chemistry, for example the preparation of fluorescence probes. For these 
reasons there are numerous synthetic strategies that have been developed. Some of 
these will be discussed below44. 
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1.4.1 Classical methods 
 
These reaction pathways include the Grover, Shah and Shah (GSS) reaction; the 
synthesis using benzophenone intermediates and the synthesis via diphenyl ester 
intermediates. However, the first xanthone synthesis was performed by Michael and 
Kostanecki45 and thus serves as the foundation from which the three traditional 
methods were developed. 
 
1.4.1.1 The Grover, Shah and Shah (GSS) reaction 
 
The GSS reaction still enjoys great popularity today because it provides a convenient 
route to xanthone preparation, specifically hydroxyxanthones, as well as the 
accessibilities of the starting materials. Another reason for its popularity is the fact 
that the reaction is a one-pot synthesis which therefore allows for the ease of the 
reaction. As shown in Scheme 3 the reaction requires a salicyclic acid derivative 38 
as well as a suitable phenol 34. These two substrates are then heated together with 
zinc chloride in phosphoryl chloride to yield the hydroxyxanthone 39. This method 
can, however, only afford the desired xanthone if a benzophenone intermediate 40 
carries an additional hydroxyl group (*) which provides an alternative cyclisation site. 
 
 
 
Scheme 3 
 
Although the GSS proves to be very efficient and versatile, it does have a number of 
limitations such as the presence of a phenolic group to direct cyclisation to the 
xanthone using the method developed by Tanase46. These limitations proved 
sufficient such that other methods have superseded this xanthone synthesis. 
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The GSS reaction remains a common and popular method for xanthone synthesis. 
Modifications to the GSS reaction are the use of Eaton’s reagents in place of the 
classical phosphoryl chloride-zinc chloride catalyst. This approach was used by Wu 
et al. in the synthesis of mangiferin 41, homomangiferin 42 and isomangiferin 4347.  
 
 
2,4-Dihydroxybenzoic acid 44 was monomethylated to afford 4-methoxy-2-
hydroxybenzoic acid 45 which was subsequently converted into 4-methoxy-2,5-
dihydroxybenzoic acid 46 under aqueous conditions. Once 46 was assembled, the 
GSS reaction with phloroglucinol 34 in the presence of Eaton’s reagent was 
conducted to afford the xanthone 47 (Scheme 4). 
 
 
 
Scheme 4 Reagents and conditions: (i) Me2SO4, 20% aq. NaOH, rt, 59%; (ii) K2S2O8, 10% 
aq. NaOH, 0 °C to rt, 60%; (ii) P2O5, MeSO3H, 80 °C, 40%. 
 
1.4.1.2 Benzophenone route  
 
The synthesis of xanthones via the benzophenone route results in a benzophenone 
derivative which is easily obtained by the Friedel-Crafts acylation of an appropriately 
substituted benzoyl chloride 48 with a phenolic derivative 49. Cyclisation of the 
benzophenone intermediate 50 could involve either a nucleophilic substitution, a 
nucleophilic addition-elimination reaction or an oxidation process (Scheme 5). 
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Scheme 5 
 
Quillinan and Scheinmann48 illustrated a more useful and efficient alternative to the 
Grover, Shah and Shah method in their synthesis of polyoxygenated xanthones. 
Their study illustrated the preparation of numerous analogues, which proved a 
limitation to the GSS method which was accompanied by unwanted demethylations. 
 
The benzophenone intermediates suitable for cyclisation to the xanthone can 
conveniently be achieved by Friedel-Crafts acylation in the presence of aluminium 
chloride in diethyl ether at room temperature. Para-acylation has been shown to be 
preferential, however, an extended reaction time of 30 hours has led to ortho-
acylation. This result thus allows for the convenient synthesis 2-hydroxy-2’-
methoxybenzophenone 51 which cyclises to the desired xanthone 52 by the 
elimination of methanol, as shown in Scheme 6. 
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Scheme 6 Reagents and conditions: (i) AlCl3, dry ether, rt, 20 h; (ii) piperidine/H2O, reflux, 
46 h. 
 
To date, there are various methods which are used to access the benzophenone 
intermediate. One such modification was achieved by Elix and co-workers49 in which 
trifluoroacetic anhydride was used in the Friedel-Crafts acylation instead of 
aluminium chloride (Scheme 7). The cyclisation step to the xanthone 53 was 
achieved by heating an aqueous solution of the benzophenone 55 under pressure. 
 
Chapter 1:  Introduction and Aims  
19 
 
OH
O
O
CH3
O (i)
O
O
CH3O
(ii)
Cl
Cl
O CH3
+
O CH3
Cl
O
O
O
CH3OH
O CH3
Cl
O
O
O
CH3OH
O CH3
Cl
OH
Cl
Cl
Cl
O
OH
CH3
OH CH3
Cl
Cl
O
O
O
CH3
O CH3
Cl
Cl
O
+
(iii)
(iv)
53
54
 
 
Scheme 7 Reagents and conditions: (i)TFAA, 1,2-dichloroethane, 0°C-reflux, 18 h; (ii) BBr3, 
CH2Cl2, –10 °C, 2 h, rt, 20 min; (iii) H2O, 120 °C, 16 h; (iv) Me2SO4, K2CO3, Acetone, 18 h 
 
Recently, the synthesis of α-mangostin 55 by Iikubo and co-workers followed the 
benzophenone route50. The benzophenone intermediate 56 was prepared from the 
parent alcohol 57 which was furnished by the coupling of 58 and a protected aryl 
anion generated from 59. The coupling of these two starting materials proved to be a 
slightly different approach involving ortho-lithiation as the key step for the preparation 
of the benzophenone intermediate.  Cyclisation of the benzophenone to afford α-
mangostin was accomplished using triphenylphosphine and carbon tetrachloride 
protocols, which constitutes a new method for xanthone synthesis (Scheme 8). 
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Scheme 8 Reagents and conditions: (i) s-BuLi, THF, –78 °C; (ii) 2-Iodobenzoic acid, 
toluene/DMSO (1:1), rt; (iii) 10% Pd/C, HCO2NH4, acetone, rt; (iv) PPh3, CCl4, THF, silica 
gel, rt. 
 
Finnegan and co-workers accessed the benzophenone intermediate 60 through a 
photo-Fries rearrangement in their synthesis of 2,5 and 4,5-dihydroxyxanthones51. 
Their initial study aimed to prepare benzophenone 61 via the condensation of 2,3-
dimethoxybenzoic acid 62 with para-dimethoxybenzene 63. However, upon analysis 
of their reaction product, it was determined that 61 was in fact not achieved but 
rather the ester 64 was prepared. This ester was then subjected to a photo-Fries 
rearrangement reaction to afford 60, the benzophenone intermediate, and the 
solvolysis product 65, with the former being the major product. Demethylation using 
hydrogen bromide afforded benzophenone 66 which was then subjected to heating 
in water in a sealed vessel furnished the xanthone 67 (Scheme 9). 
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Scheme 9 Reagents and conditions: (i) Pyridine, reflux, 4.5 h; (ii) Irradiation, EtOH, 30-40 
°C, 9 h; (iii) Glacial acetic acid, 48% HBr, reflux, 4 h; (iv) H2O, bomb, 225 °C, 17 h. 
 
1.4.1.3 Diaryl ether route 
 
Xanthones synthesized from diaryl ethers incorporate an Ullmann condensation or a 
related ether synthesis. The general reaction involves phenols 68 reacting with 
ortho-halogenated benzoic acids 69 to yield the diaryl ether intermediate 70. This 
intermediate can then be cyclised to the xanthone 71 by the electrophilic 
cycloaddition of the diaryl ether, as shown in Scheme 10. 
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Scheme 10 
 
This synthetic route was used by Sousa and co-workers in the synthesis of kielcorin 
derivatives52. Ether formation 72 was achieved by the condensation of methyl-2-
bromobenzoate 73 and 3,4-dimethoxyphenol 74 in the presence of copper. The ester 
containing diaryl ether 72 was hydrolysed to form the acid 75. Cyclisation of 75 was 
achieved by reacting it with either LDA in THF or with AcCl in the presence of sulfuric 
acid to yield xanthones 76 and 77. Demethylation afforded xanthones 78 and 79 
(Scheme 11).  
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Scheme 11 Reagents and conditions: (i) Cu, K2CO3, Pyridine, reflux, 26 h; (ii) MeOH/THF, 
H2O, NaOH, rt, 96 h; (iii) AcCl, H2SO4, rt, 10 min; (iv) LDA, THF, 0°C to rt, 2 h (v) Toluene, 
AlCl3, reflux, 8 h 
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Reisch and co-workers have prepared xanthone derivatives in their synthesis toward 
acronycine isosters53. The diaryl ether intermediate 80 was prepared by the Ullmann 
condensation of 2-chloronicotinic acid 81 with 3,5-dimethoxyphenol 82. Cyclisation of 
the diaryl ether 80 to furnish azaxanthone 83 was achieved by using polyphosphoric 
acid (Scheme 12). 
 
 
 
Scheme 12 Reagents and conditions: (i) Cu, K2CO3, DMF; reflux, 10 h; (ii) Polyphosphoric 
acid, 110 °C, 3 h. 
 
Elix and co-workers accessed the diaryl ether 84 via a Smiles rearrangement of the 
diaryl ester 8549. Ester 85 formation was effected by the condensation of benzoic 
acid 86 and phenol 87 in the presence of N,N’-dicyclohexylcarbodiimide (DCC). The 
diaryl ester was treated with potassium carbonate in dry DMSO to effect the Smiles 
rearrangement to afford the carboxylic acid 85. Cyclisation was then achieved by 
treating the carboxylic acid with trifluoroacetic anhydride to furnish the xanthone 88 
(Scheme 13). 
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Scheme 13 Reagents and conditions: (i) DCC, toluene, dry ether, rt, 24 h; (ii) K2CO3, dry 
DMSO, 80 °C, N2, 16 h; (iii) dry toluene, TFAA, rt, 17 h. 
 
1.4.2 Unconventional methods 
 
Over the years, some non-conventional methods for the synthesis of xanthones have 
been reported. Although limited in their application, these methods laid the 
foundation for more efficient and high-yielding methods44. Some of these non-
conventional methods will be highlighted in the following section. 
 
1.4.2.1 Claisen cyclisation of poly-β-ketide 
 
Harris and co-workers demonstrated a biomimetic pathway for the synthesis of 
lichexanthone 89, a naturally occurring secondary metabolite54. The first step in their 
synthesis was the reaction of dilithioacetylacetone 91 with methyl orsellinate 90 to 
furnish the triketone 92. Carboxylation of 92 afforded triketo acid 93 which was then 
esterified to afford the ester 94. Under basic conditions the ester 94 was converted 
into the benzophenone intermediate 95 which involved Claisen cyclisation and chain 
cleavage reactions. The benzophenone intermediate 95 was then heated in 
methanolic KOH followed by methylation to afford the xanthone 89 (Scheme 14). 
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Scheme 14 Reagents and conditions: (i) THF, 16 h, rt; (ii) THF, 0 °C, CO2 bubbling, 5 min; 
(iii) Diethyl ether, CH2N2, 30 sec; (iv) KOH(aq), rt, 70 h; (v) 10% KOH/MeOH, reflux, 7.5 h; (vi) 
Diethyl ether, CH2N2, rt, 1 min.  
 
1.4.2.2 The Robinson-Nishikawa method 
 
This method is a variant of the Hoesch synthesis and is known to proceed via 
benzophenones involving ketimine intermediates. In 1922, Robinson demonstrated 
the ketimine intermediate pathway for the preparation of 1,3-dihydroxyxanthone 9655. 
The reaction involved the condensation of phloroglucinol 34 and salicylonitrile 97 in 
the presence of zinc chloride to afford the ketimine intermediate 98. Under basic 
hydrolysis conditions, the ketimine intermediate was converted into the xanthone 96 
(Scheme 15). 
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Scheme 15 Reagents and conditions: (i) ZnCl2, HCl, 2 h; (ii) NaOHaq, reflux  
 
1.4.2.3 Synthesis of xanthones from thioxanthone 
 
Bennet et al. synthesized 99 via thioxanthone intermediates56. Thioxanthone 100 
was converted into hydroxybenzophenone sulfinic acid 101 by conducting the 
reaction under basic conditions followed by acidification. The hydroxybenzophenone 
sulfinic acid 101 was then heated under basic condition to afford the xanthone 99 as 
shown in Scheme 16. 
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Scheme 16 Reagents and conditions: (i) NaOH, dioxane/H2O, reflux, 5 h; (ii) NaOHaq, reflux, 
4 h  
 
1.4.2.4 The Tanase Method for synthesis of xanthones 
 
This method has proved to be useful in the preparation of partially methylated 
polyhydroxyxanthones and involves xanthene intermediates. Davies et al. applied 
the Tanase method in their preparation of 3,8-dihydroxy-1-methoxyxanthone 10257. 
2,6-Dihydroxybenzaldehyde 103 was reacted with 1,3-dihydroxy-5-methoxybenzene 
104 under acidic conditions to afford the tricyclic ketone 105. Compound 105 was 
then reduced using H2 and a catalyst to afford the xanthene intermediate 106. The 
phenol on the xanthene intermediate 106 was protected to give 107 and then 
oxidised to yield xanthone 108 which was then converted into the desired xanthone 
102 with the loss of acetic acid (Scheme 17).  
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Scheme 17 Reagents and conditions: (i) AcOH, HCl; (ii) cat. H2; (iii) Ac2O; (iv) CrO3;   
 
1.4.3 New methodology 
 
In more recent years, the emergence of other methods to construct the xanthone 
core has risen. The main advantages of these new methods include the 
regioselective construction of highly substituted xanthones. In this section, some of 
these methods will be highlighted. 
 
1.4.3.1 The Hauser method for the synthesis of xanthones 58 
 
Hauser and co-workers accomplished one of the first total syntheses of bikaverin 
109, by condensing (phenylsulfonyl)isobenzofuranones with chromones to afford 
xanthones regiospecifically. 
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In the classical methods, either the carbonyl bridge or ether linkage is synthesized 
first before the pyranone ring is formed. The approach followed by Hauser et al. 
followed a different approach in which the oxygen containing ring is incorporated into 
the starting materials. Condensation of the anion of 110 and chromone 111 afforded 
the xanthone 112. Xanthone 112 was then subjected to an oxidation followed by 
demethylation to afford bikaverin 109 (scheme 18) 
 
O
CH3
O
O O
O
O
O
O
SO O
O
CH3
O
O OH
OH
O
O
O
O
CH3
O
O O
O
O
O
O
O
CH3
O
O OH
OH
O
O
O
(i)
(ii)
(iii)
+
109
112110111
 
 
Scheme 18 Reagents and conditions: (i) LiO-t-Bu, THF, –78°C and reflux; (ii) Ag2CO3-Celite; 
(iii) LiI, DMF  
 
The methodology was then extended to the preparation of xanthones which contain 
angular polycyclic aromatic systems 113 59. This was achieved by condensing 
benzopyranophthalide 114 with various Michael acceptors 115. One example is 
shown in Scheme 19. 
 
 
 
Scheme 19 Reagents and conditions: (i) LiO-t-Bu, THF, –78°C and reflux 
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This method provided a high yielding, general approach to xanthone preparation, 
both linear and polycyclic. Michael acceptors such as chromones therefore expand 
the use of sulfone annelation for regiospecific xanthone preparation58. 
 
1.4.3.2 The Liebeskind method for the synthesis of xanthones 60 
 
Liebeskind and co-workers have developed a flexible approach for the synthesis 
highly-substituted xanthones. Their methods relied on cyclobutenediones as 
scaffolds for the construction of these xanthones. The synthetic strategy involved the 
benzannulation of the intermediate 116 which undergoes benzannulation and 
deprotection to afford the xanthone nucleus 117. To prepare intermediate 116, the 
dianion of dithiane protected salicylaldehyde 118 was fused to a squaric acid 
derivative 119, which yielded the dithiane-protected benzopyrone-fused 
cyclobutenedione 120. Nucleophilic addition of various lithiates such as 121 to 
cyclobutenedione 120 followed by O-acetylation afforded intermediate 116. Attack by 
the lithiate occurred exclusively at the carbonyl group opposite to the bulky dithiane 
moiety. The intermediate is exceptionally prone to benzannulation and results in the 
benzannulated product 122 which is deprotected to afford the xanthone 117 
(Scheme 20). 
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Scheme 20 Reagents and conditions: (i) t-BuLi, THF, –78 °C to 0 °C; (ii) 10 mol % pTSA, 
CH2Cl2, rt, 72 h; (iii) THF, –78 °C, Ac2O, reflux; (iv) HgCl2/CaCO3, mesitylene/H2O, reflux 
 
Liebeskind and co-workers also attempted the preparation of angular-fused 
xanthone using the cyclobutenedione-based methodology61. Cyclobutenedione 123 
was reacted with the substituted N-methylpyrrole 124 to afford adduct 125. Xanthone 
126 was then produced through the benzannulation of 127. This transformation is 
believed to be produced by a cascade of electrocyclization reactions and elimination 
of methanol which is initiated by the ring-opening of cyclobutenedione 125 (Scheme 
21). 
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Scheme 21 Reagents and conditions: (i) THF, –78 °C; (ii) MeOTf, -78 °C to rt, 64 h; (iii) 
mesitylene, reflux 
 
These methods developed by Liebeskind and co-workers allow for control of the 
regiochemistry of the desired products. Another aspect is the short reaction times as 
well as being high yielding which will allow for application in the total synthesis of 
natural xanthones.  
 
1.4.3.3 The Casillas method for the synthesis of xanthones62 
 
Casillas and co-workers described a new synthetic method for the preparation of 
xanthones which takes advantage of the high electrophilicity of N-alkylnitrilium salts. 
Their study was based on an earlier study by Meerwein which demonstrated that 
nitriles are able to be activated by N-alkylation in the presence of Lewis acids. This 
allows these nitriles to become highly electrophilic nitrilium salts63. The acylation 
reaction of these alkylnitrilium salts proves to surpass the Houben-Hoesch acylation 
method. This is due to the enhanced electrophilicity of the intermediate. 
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2-Fluoro-6-methoxybenzonitrile 128 was reacted with Lewis base, SbCl5 and 2-
chloropropane to afford the N-isopropylnitrilium salt 129. Intermolecular imino-
acylation of ester 130 by the nitrilium salt 129 furnished the benzophenone ketimine 
131. The benzophenone ketimine 131 was then treated with excess base to 
hydrolyse the intermediate 131 to the desired xanthone 132 as shown in Scheme 
22.  
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Scheme 22 Reagents and conditions: (i) SbCl5, 2-chloropropane, CH2Cl2, rt, 2 h; (ii) reflux, 
60 h, CH2Cl2; (iii) K2CO3, MeCN, reflux, 23 h, MeOH/H2O. 
 
Casillas et al. therefore provided a general route to prepare highly substituted 
xanthones. They achieved this by taking advantage of the reactivity of N-
alkylnitrilium salts by employing Friedel-Crafts methodology64. 
 
1.4.3.4 The Ghosh method for the synthesis of xanthones  
 
In 1993 Ghosh and Sahana reported on a method for the preparation of xanthones 
by an intermolecular Michael initiated ring closure (MIRC)65. Chromones 133 and 
134 undergo an MIRC in the presence of a base to afford benzoxanthene 135. 
These benzoxanthenes then undergo a base catalysed deacylative hydroxyl 
elimination followed by pyran ring opening to furnish xanthones, such as 136 
(Scheme 23).  
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Scheme 23 Reagents and conditions: (i) Pyridine, piperidine, reflux, 8h 
 
Ghosh et al. then discovered a method for the preparation of xanthones using a 
Diels-Alder [4+2] cycloaddition reaction66. The method involved the cycloaddition of 
chromone 137, which acts as a dienophile, and enamine 138 to afford intermediate 
139. Intermediate 139 then undergoes base catalysed deacylative hydroxyl 
elimination followed by pyran ring opening to yield xanthone 140 (scheme 24).  
 
 
Scheme 24 Reagents and conditions: (i) DMF, reflux, 8 h 
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This Diels-Alder cycloaddition has also been used on alkyne substrates to prepare 
xanthones. This method also showed that the diene undergoes a Diels-Alder 
cycloaddtion with relatively weak dienophiles as well as reactive dienophiles67. 
 
1.5 Background to, and aims of, this project 
 
Interest of our research laboratories in these xanthones started in 1988 by de Koning 
and Giles with the synthesis of bikaverin, 10968. Bikaverin 109 was isolated by both 
Kjaer69 and Cornforth70 simultaneously. Kjaer also isolated norbikaverin 141, a 
derivative of bikaverin. Bikaverin is known to be a wine-red pigment and has been 
isolated from several species of the fungal genera Fusarium, Gibberella as well as 
Mycogone. Among the biological activities bikaverin is known to possess, an 
important one is its antitumour activity.  
 
 
 
de Koning and co-workers started the xanthone synthesis by constructing the 
carbonyl bridge which was prepared using a mild Friedel Crafts reaction. This was 
achieved using trifluoroacetic anhydride (TFAA) with the prepared naphthalene 
derivative 142 and the aryl acid 143, to afford the intermediate as a single 
regioisomer 144. Compound 144 was then deprotected using palladium on carbon in 
the presence of hydrogen under pressure to afford the phenol 145 which was 
followed by oxidation using DDQ, which afforded the unexpected spiro-compound 
146. The spiro compound 146 was then hydrolyzed to the desired trione 147 using 
aqueous trifluoroacetic acid (TFA) followed by pyrolytic isomerisation to yield 
xanthone 109 as shown in Scheme 25. 
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Scheme 25 Reagents and conditions: (i) TFAA, CH2Cl2, rt, 90 h, 51%; (ii) 10% Pd/C, H2, 5 
bar, 1 h, 80%; (iii) DDQ, benzene, rt, 68 h, 61%; (iv) TFA (aq), CH2Cl2, rt, 5 min, 94%; (v) 
200 °C, 1.1 bar, 1 h, 93%. 
 
Initial studies conducted at Wits aimed to test the flexibility of the de Koning and 
Giles methodology towards the synthesis of simple and complex xanthones. 
Previously in our laboratories, the synthesis of the xanthones using the de Koning 
and Giles method proved to be unsuccessful. Following de Koning et al., the 
carbonyl bridged intermediate 148 was constructed using a Friedel Crafts reaction 
with trifluoroacetic anhydride (TFAA) with the naphthalene derivative 149 and the 
aryl acid 150, in a yield of 30% (Scheme 26). Owing to the low yield achieved from 
the Friedel Crafts reaction, another method was sought to form the carbonyl bridge. 
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Scheme 26 Reagents and conditions: (i) TFAA, CH2Cl2, rt, 48 h, 30%. 
 
A procedure followed by Argade and co-workers in their pursuit to synthesize 
nigrolineaxanthone 151 and osajaxanthone 152 was applied71.  
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In their approach they constructed the carbonyl bridge of 153 by reacting n-
butyllithium with 2-bromo-1,3,5-trimethoxybenzene 154 followed by methyl 2-5-
(dibenzyloxy)benzoate 155 as shown in Scheme 27. 
 
 
 
Scheme 27 Reagents and conditions: (i) n-BuLi, THF, –78 °C, 90 min. 
 
The construction of the carbonyl bridge was then performed using the method of 
Argade and co-workers. In our work commercially available 1,4-
dimethoxynaphthalene was brominated to yield 156. Compound 156 was then 
reacted with n-butyllithium followed by benzyl 2-(benzyloxy)benzoate 157 to afford 
the ketone 158 in a yield of  89%. Removal of the benzyl group using palladium on 
carbon in a hydrogen atmosphere produced phenol 159, shown in Scheme 28. 
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Scheme 28 Reagents and conditions: (i) n-BuLi, THF, –78 °C, 90 min, 89%; (ii) 5% Pd/C, 
H2, methanol, 5 atm, 18 h, 97%. 
 
The phenol 159 was then subjected to oxidation using DDQ as employed by de 
Koning and Giles, which was the key step in the formation of the spiro-complex 160 
(Scheme 29). After many attempts and the changing of various reaction parameters, 
only starting material was recovered.  
 
 
 
Scheme 29 Reagents and conditions: (i) DDQ, benzene, rt, 72 h; (ii) DDQ, benzene, reflux, 
72 h; (iii) DDQ, chloroform, rt, 72 h; (iv) DDQ, chloroform, reflux, 72 h. 
 
After the oxidation reaction using DDQ met with failure, another oxidising agent was 
used, namely ceric ammonium nitrate (CAN). This was attempted due to literature 
precedence by Whalley and co-workers who found that 1,4-benzoquinones can 
undergo 1,4-Michael addition to afford xanthone compounds72. Using CAN, Naidoo 
attempted the oxidation of 159 in the hopes of producing quinone 161 which could 
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undergo 1,4-Michael addition to afford the xanthone 16273. However, the reaction 
surprisingly produced the dione 163 (Scheme 30). 
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Scheme 30 Reagents and conditions: CAN, CH3CN/H2O, rt, 1.5 h, 72% 
 
Having produced the unexpected dione 163, the synthetic route was tested on a 
simpler, less substituted system. The route produced the expected intermediates. 
Therefore a simpler carbonyl bridge compound was prepared from 2-bromo-1,4-
dimethoxybenzene 164 and benzyl 2-(benzyloxy)benzoate 157 which affording 
intermediate 165 was then deprotected to afford the phenol 166 in excellent yield. 
The phenol 166 was then oxidised using CAN to afford the expected dione 167 and 
an additional product, in higher yield the xanthone 168, shown in Scheme 31. 
 
 
Chapter 1:  Introduction and Aims  
40 
 
  
 
Scheme 31 Reagents and conditions: (i) n-BuLi, THF, –78 °C, 90 min, 72%; (ii) 5% Pd/C, 
H2, 5 atm, rt, 24 h, 90%; (iii) CAN, CH3CN, rt, 1.5 h, 168 74% and 167 15% 
 
The aims of this project have therefore been divided into two parts. Firstly, it was 
aimed to reproduce and confirm the findings of Naidoo and elucidate the mechanism 
for both the xanthone and dione formation. Secondly with these methods in place, 
we hope to utilise the synthetic strategy developed for the synthesis of a range of 
xanthones and diones, differing in their substitution patterns. 
 
The starting point of this project was the synthesis of dione 163. Dione 163 can be 
disconnected to the benzophenone intermediate 159 (following the work of Naidoo) 
which we planned to synthesize using a DOM reaction with n-BuLi. The precursors 
for this step was the protected salicyclic acid 157 and 1,4-dimethoxynaphthalene 
148. 
 
 
 
Scheme 32 
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In a similar manner and following the work of Naidoo, xanthone 168 could be 
disconnected to the benzophenone intermediate 166, which we planned to 
synthesize from the protected salicyclic acid 157and 1,4-dimethoxybenzene 169. 
 
 
 
Scheme 33 
 
Scheme 34 details the proposed steps for the formation of the ester 157 and 2-
bromo-1,4-dimethoxynaphthalene 156, which were the initial starting materials for 
the proposed synthesis. The commercially available salicyclic acid 149 is protected 
using benzyl bromide while 1,4-naphthoquinone 170 is converted into the 
hydroquinone 171 followed by the protection of the hydroxyl groups as methyl ethers 
148. 
 
 
Scheme 34 
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Using DOM reaction methodology, 2-bromo-1,4-dihydroxynaphthalene 156 is 
expected to undergo halogen-metal exchange with butyllithium before reaction with 
ester 157 to afford the benzophenone 158. This benzophenone intermediate should 
then undergo deprotection to furnish the free alcohol 159. Compound 159 will then 
be subjected to oxidation conditions using CAN to afford the xanthone related 
product 163. 
 
 
Scheme 35 
 
Using similar methodology to that for the preparation of 163, xanthone 168 and dione 
167 are expected to be prepared. Once this methodology has been applied to these 
systems to afford relatively simple xanthones, it will be applied to more complex 
systems, e.g. substituted salicyclic acids to afford more complex xanthones as 
shown in Scheme 36. 
 
Scheme 36
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2 Chapter 2: Results and Discussion 
 
2.1 Synthesis of phenol 159 
 
The present synthesis began with the preparation of the starting materials benzyl 2-
(benzyloxy)benzoate 157 and 2-bromo-1,4-dimethoxynaphthalene 156 (Figure 1). 
 
 
 
Figure 1 
 
Salicyclic acid 149 was treated with 3 equivalents of both potassium carbonate and 
benzyl bromide in acetone. Concentrated solutions were found to be optimal for the 
synthesis of the dibenzylated product 157. Both the carboxylic acid proton (pKa  5) 
and the phenolic proton (pKa  10) are acidic enough to be deprotonated by the weak 
potassium carbonate base. Addition of benzyl bromide results in the dibenzylated 
compound. The desired compound 157 was synthesized in a yield of 94%. 
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Scheme 37 Reagents and conditions: (i) K2CO3, benzyl bromide, acetone, ∆, 18h, 94% 
 
The presence of two singlets at δ 5.13 and 5.33 in the 1H NMR spectrum of 157, 
each integrating for two protons, was a clear indication that both hydroxyl groups had 
been protected as the benzyl ether and ester respectively. These signals 
corresponded to the methylene groups. The singlet further downfield was assigned 
7-H, as the ester methylene protons are the more deshielded due to the electron 
withdrawing effects of the carbonyl group. The doublet of doublet furthest downfield 
was assigned to 3-H, as similar to 7-H it is the most deshielded aromatic proton due 
to the electron withdrawing effects of the carbonyl group. This doublet of doublet 
clearly shows ortho and meta coupling to 5-H and 4-H respectively, with coupling 
constants of J = 7.7 and 1.7 Hz respectively. The 13C NMR spectrum showed two 
signals at δ 70.5 and 66.6 which correspond to the two methylene carbons. As 
observed in the 1H MNR spectrum, the signal at δ 70.5 which appears further 
downfield is assigned to the benzyl ester moiety. Another characteristic signal in the 
13C NMR spectrum is the signal at δ 166.2 which is an indication of the carbonyl 
functional group. Further confirmation of the identity of the dibenzylated compound is 
observed in the IR spectrum. The IR spectrum showed a strong signal at 1716 cm-1 
which is characteristic of carbonyl stretching. The absence of a broad signal at 
around 3300 cm-1 is a clear indication that compound 157 did not contain hydroxyl 
groups which further confirmed the absence of both the carboxylic acid proton and 
the phenolic proton. A final comparison was made using the melting point of 
compound 157. The melting point of compound 157 was determined as 48-50 °C 
which is close to that reported in the literature being 50-51 °C74. 
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Commercially available 1,4-dimethoxynaphthalene 148 was treated with 1 mole 
equivalent of N-bromosuccinimide (NBS) in dichloromethane (DCM). NBS has been 
used as a mild brominating agent for polyalkoxyaromatic systems such as 1,4-
dimethoxybenzene 169. 1,4-Dimethoxynaphthalene 148 is electron rich and is 
therefore known to undergo electrophilic aromatic substitution under mild conditions. 
Hence, the reaction between 1,4-dimethoxynaphthalene 148 and NBS was expected 
to be high yielding. The methoxy groups present donate electron density into the ring 
and are known to be ortho directors. Having only added one equivalent of NBS, 
bromination at one position was expected and achieved. The desired compound 156 
was obtained in a yield of 92% (Scheme 38). 
 
 
 
Scheme 38 Reagents and conditions: (i) NBS, DCM, ∆, 18h, 92% 
 
The formation of 156 was confirmed spectroscopically by examining the 1H and 13C 
NMR spectra. The 1H NMR spectrum of 156 showed the presence of two singlets at 
δ 3.97 and 3.98, each integrating for three protons. This observation was an 
indication that the symmetry of 1,4-dimethoxynaphthalene 148 was now absent and  
that the environments of the two methoxy groups were thus different suggesting 
bromination ortho to one of these methoxy groups. Another singlet, further downfield 
at δ 6.91 which integrated for one proton was assigned as 3-H. The 13C NMR 
spectrum showed two upfield signals at δ 55.7 and 61.3 which are characteristic of 
methoxy group carbons. Two downfield signals at δ 146.7 and 152.1 indicated the 
presence of carbons attached directly to methoxy groups. Further confirmation was 
provided by the signal at δ 111.8 which is in the expected region for an aromatic 
carbon directly attached to a halogen. The NMR spectra analysed for compound 156 
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compared well with the literature. The melting point obtained (56-58 °C) was in 
reasonable agreement with that reported in the literature of 54-55 °C75.  
 
Having O-benzylated the salicyclic acid 149 to afford 157 and brominated the 1,4-
dimethoxynaphthalene 148 to yield 156, the formation of the ketone could be 
performed. This was achieved over two steps using halogen-metal exchange 
followed by coupling of the metalated species to the ester (Scheme 39). Lithium-
halogen exchange using n-BuLi (1.0 equiv.) was conducted on 2-bromo-1,4-
dimethoxynaphthalene 156, which was followed by treatment of the lithiated species 
with benzyl 2-(benzyloxy)benzoate 157 to produce the benzophenone intermediate, 
[2-(benzyloxy)phenyl](1,4-dimethoxynaphthalen-2-yl)methanone 158 in 84% yield 
(Scheme 39). Great care needed to be taken in the addition of the lithiated species 
to benzyl 2-(benzyloxy)benzoate 157 in order to prevent the reactive lithiated species 
from adding twice to the ester. However, the presence of the bulky benzyloxy groups 
are believed to assist in single addition, possibly due to steric hindrance.  
 
 
 
Scheme 39 Reagents and conditions: (i) THF, –78 °C, n-BuLi (1.0 equiv.), 45 min, benzyl 2-
(benzyloxy)benzoate 157, 30 min, 84% 
 
Confirmation of the successful synthesis of 158 was obtained from both the 1H and 
13C NMR spectra. The 1H NMR spectrum of 158 showed two singlets at δ 3.59 and 
3.91 which integrated for three protons each and were assigned to the methoxy 
groups at positions 1 and 4. The presence of a singlet at δ 4.98 integrating for two 
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protons was due to the methylene substituent. Another characteristic feature of 158 
was the singlet at δ 6.88 which was due to the isolated proton at 3-H. Further 
confirmation that the carbonyl bridge was formed was evident from the downfield 
signal at δ 196.3 in the 13C NMR spectrum which is characteristic of the presence of 
a ketone. The peaks at δ 55.8 and 63.6 correspond to the methoxy group carbons 
while the signal at δ 70.3 was due to the methylene carbon. The 13C NMR spectrum 
also showed three peaks at δ 157.5, 151.7 and 150.3 which all correspond to 
carbons attached to alkoxy groups. The peaks at δ 151.7 and 150.3 are due to the 
carbons attached to the methoxy groups. A slight shift in the δ values compared to 
that of the precursor 156, suggests that the carbon-halogen bond is no longer 
present. The peak at δ 157.5 is thus due to the carbon bonded to the benzyloxy 
group.  The IR spectrum contained a strong signal at 1734 cm-1 which is indicative of 
the presence of a carbonyl group. Conclusive proof for the formation of 158 was 
obtained from the high resolution mass spectrum of the product, which showed a 
molecular ion at m/z 398.1523 in good agreement with the expected mass of the 
molecule (m/z 398.1518). 
 
The benzophenenone intermediate 158 then underwent a hydrogenolysis reaction to 
facilitate the removal of the O-benzyl group. This was easily achieved by stirring 158 
and palladium on carbon in methanol and subjecting this mixture to hydrogen gas at 
a pressure of 1 atmosphere (Scheme 40).  
 
 
 
Scheme 40 Reagents and conditions: (i) 5% Pd/C, methanol, H2(g), 1 atm, 24h, 97% 
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There was a very small shift in the Rf of the product as compared to the starting 
material 158 which may be due to intermolecular hydrogen bonding to the ketone.  
The removal of the benzyl group to furnish the phenol was unequivocally confirmed 
by NMR spectroscopic data. The most prominent change was the appearance of a 
singlet at δ 12.25, integrating for one proton suggesting the presence of a hydrogen-
bonded hydroxyl group, and the absence of the singlet at δ 4.89 due to the 
methylene group of the benzyl substituent. This confirmed that the benzyl group was 
no longer present. The 13C NMR spectrum was simplified by the disappearance of a 
range of signals, corresponding to aromatic carbons and more importantly to the 
methylene carbon which was previously present at δ 70.3. The IR spectrum also 
indicated the absence of the benzyl group by the presence of a broad stretching 
band at 2970 cm-1, which is characteristic of a hydrogen-bonded hydroxyl group. The 
high resolution mass spectrum of the molecule 159 found at m/z 308.1048 was also 
in good agreement with the expected mass of m/z 308.1049.   
 
With 159 in hand, we were now at the stage to form the ether bridge to hopefully 
afford the xanthone or our xanthone-related product, upon treatment with ceric 
ammonium nitrate.  
 
2.2 Oxygen heterocycle formation by CAN mediated oxidations 
 
Ceric ammonium nitrate (CAN) has recently emerged as a versatile reagent for 
oxidative electron transfer. Castagnoli Jnr and co-workers 76 demonstrated the use of 
CAN as an oxidizing agent for the preparation of quinones from hydroquinones and 
even formulated a mechanism for this transformation. In their study, they oxidised 
1,4-dimethoxy-2,3,5,6-tetramethylbenzene 172 in the presence of 95% isotopically 
enriched H2O (18O). This provided a doubly labelled duroquinone 173. The reaction 
is believed to proceed by aryl-oxygen bond cleavage with a net formation of the 
quinone and 2 moles of methanol (Scheme 41). 
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Scheme 41 
 
Due to the advantages associated with CAN, which range from low toxicity to its 
solubility in a range of organic solvents, a large number of research papers and 
review articles have been published on its applications in recent years77.  
 
2.2.1 Synthesis of dione 163 
 
Unfortunately, when 159 was treated with ceric ammonium nitrate in aqueous 
acetonitrile, neither the expected quinone 161 nor the corresponding xanthone 162 
was isolated from the reaction (Scheme 30). Surprisingly the reaction went to 
completion rather quickly and upon analysis the expected xanthone-related product 
163 was isolated (Scheme 30). This result was in agreement with that obtained by 
Naidoo 73. 
 
 
 
Scheme 30 Reagents and conditions: (i) CAN, H2O/CH3CN/CHCl3, rt, DCM, ∆, 10 min, 72% 
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Upon analysis of the 1H NMR spectrum, showed  the presence of a singlet at δ 3.03 
which integrated for three protons, and which could be assigned to a methoxy group. 
This suggested that the expected products 161 or 162 had in fact not formed. The 
methoxy signal appeared further upfield and on closer inspection it was found that 
this was a consequence of it being a constituent of an acetal. The absence of the 
hydroxyl signal at δ 12.25 suggests that the ether linkage of the xanthone was 
formed. The 1H NMR spectrum also showed a singlet at δ 7.26 which is 
characteristic of a quinone proton, 6-H. Furthermore, the doublet furthest downfield 
at δ 8.16 is characteristic of an aromatic proton adjacent to a carbonyl group. This 
signal appears furthest downfield as it is the most deshielded proton due to the 
electron withdrawing effects of the carbonyl bridge. The 13C NMR spectrum showed 
two signals at δ 184.0 and 181.0 which suggested that the product contained two 
carbonyl carbons while the presence of the signals at δ 157.8 and 51.5 which are 
due to a carbon bonded to a methoxy group and a methoxy carbon respectively, 
confirms that the a methoxy group was present in our product. Further confirmation 
that the ether linkage was possibly achieved was absence of a hydroxyl peak at 
2970 cm-1 in the IR spectrum. The high resolution mass spectrum showed a 
molecular ion at m/z 292.0778 which coincided with the expected mass of m/z 
292.0778. A crystal structure was obtained in the initial xanthone study conducted by 
Naidoo73. This result confirmed Naidoo’s unexpected finding. 
 
The mechanism postulated for the formation of 163 is shown in Scheme 41. It is 
believed that the CAN oxidises the dimethoxynapthalene system which results in a 
radical cation 174 or which may proceed via the phenoxy oxygen radical 175. The 
aromatic radical cation can then undergo nucleophilic addition with the phenol to 
afford radical 176 which can undergo further oxidation with another equivalent of 
CAN to afford a cation 177 which is stabilised as the oxonium ion 178 to which water 
can add to yield 179. Following elimination of methanol from 179 the obtained 
product 163 would be formed. This reaction represents new unexpected 
methodology for making a xanthone-like product.  
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Scheme 41 
 
2.3 Synthesis of dione 167 and xanthone 168 
 
After this unexpected result (initially obtained by Naidoo) we then decided to try the 
reaction on related substrates to gauge the versatility of this novel reaction. Instead 
of using 1,4-dimethoxynaphthalene 148 as the starting material 1,4-
dimethoxybenzene 169 was used in this investigation. We envisaged a similar 
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synthetic route as followed for the synthesis of synthesis of 12a-methoxy-5H-
benzo[c]xanthenes-5,7(12aH)-dione 163 (Scheme 42). 
 
 
 
Scheme 42 
 
Commercially available 1,4-dimethoxybenzene 169 was treated with 1 mole 
equivalent of NBS in DCM and underwent electrophilic substitution to afford the 
halogenated product, 2-bromo-1,4-dimethoxybenzene 164. The desired compound 
164 was obtained in a yield of 89% as a colourless oil using the procedure by 
Bloomer and co-workers78. 
 
 
 
Scheme 43 Reagents and conditions: (i) NBS, DCM, ∆, 48 h, 89% 
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The 1H NMR spectrum showed the presence of two singlets at δ 3.74 and 3.82, each 
integrating for three protons. These two signals correspond to the methoxy groups 
and appeared as two separate signals due to the loss in symmetry of the starting 
material 169 upon halogenation. The 1H NMR spectrum also clearly indicated a 
downfield singlet which integrates for one proton and was assigned as 3-H. In the 
13C NMR spectrum, the presence of three quaternary carbons attested to the fact 
that halogenation of 169 occurred successfully. These three signals are at δ 154.0 
and 150.3, which are characteristic of a carbon bonded to a methoxy group, and 
δ113.6 which is due to the carbon bonded to the bromine atom. The NMR 
spectroscopic results unambiguously confirmed that the compound was 2-bromo-
1,4-dimethoxybenzene 164. 
 
With the starting materials prepared, the linking carbonyl bridge could then be 
constructed in a similar manner as before. Lithiation using n-BuLi (1.0 equiv.) on 
substrate 2-bromo-1,4-dimethoxybenzene 164 was conducted. Treatment of benzyl 
(2-benzyloxy)benzoate 157 with the lithiated species produced the benzophenone 
intermediate, [2-(benzyloxy)phenyl](2,5-dimethoxyphenyl)methanone 165 in 88% 
yield. Once again great care needed to be taken in the addition of the lithiated 
species to benzyl 2-(benzyloxy)benzoate 157 in order to prevent the reactive lithiated 
species from adding twice to the ester (Scheme 44).  
 
 
 
Scheme 44 Reagents and conditions: (i) THF, –78 °C, n-BuLi (1.0 equiv.), 45 min, benzyl 2-
(benzyloxy)benzoate, 30 min, 88% 
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Confirmation that the reaction was successful for the synthesis of 165 was obtained 
from both the 1H and 13C NMR spectra. The 1H NMR spectrum of 165 showed a 
singlet at δ 4.94 integrating for two protons which was due to the methylene group. 
Another characteristic feature of 165 was the doublet of doublets at δ 7.59 which 
was due to the proton at 4-H and showed ortho and meta coupling of J= 7.6 and   
1.7 Hz to 3-H and 6-H respectively. The observation of the meta coupling was likely 
due to a loss of the highly electron-withdrawing bromine. The 13C NMR spectrum 
showed a downfield signal at δ 195.4 which further confirmed the presence of the 
carbonyl bridge. The peaks at δ 55.9 and 56.5 correspond to the methoxy group 
carbons while the signal at δ 70.1 was due to the methylene carbon. The 13C NMR 
spectrum also showed three peaks at δ 157.2, 153.5 and 152.8, which all 
correspond to aryl carbons attached to alkoxy groups. The IR spectrum contained a 
strong signal at 1734 cm-1 in the IR spectrum, which is characteristic of a carbonyl 
group. The high resolution mass spectrum showed a molecular ion at m/z 348.1346 
consistent with the formula C22H20O4 (calculated 348.1362) thus further confirming 
the formation of product 165. 
 
 
 
Scheme 45 Reagents and conditions: (i) 5% Pd/C, methanol, H2(g), 1 atm, 24 h, 89% 
 
The ether 165, was then subjected to hydrogenolysis in methanol to afford the 
phenol 166 in 89% yield. In the 1H NMR spectrum of 166, the signal for the 
methylene proton was no longer present while a new signal at δ 12.04 was observed 
which is characteristic of the proton of the phenol group. Conclusive evidence for the 
formation of 166 was obtained from the mass spectrum of the product, which 
showed a molecular ion at m/z 258.0883 in good agreement with the expected mass 
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of m/z 258.0892. The analytical data for the prepared compound compared well with 
those presented in the literature79. 
 
Oxidation of the phenol 166 was achieved by stirring an aqueous acetonitrile solution 
of 166 in the presence of CAN at room temperature for 24 hours. TLC analysis of the 
reaction mixture showed the formation of two new product spots. The first and major 
product was the expected product 2-methoxyxanthone 168 while the second and 
minor product 167 was the expected dione. 
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Scheme 46 Reagents and conditions: (i) CAN, H2O/CH3CN/CHCl3, rt, 10 min, 168 74% and 
167 15%.  
 
Confirmation of the structure of the major product was evident in the 1H NMR 
spectrum. The signal at δ 3.83 integrated for three protons, which is characteristic for 
an aromatic methoxy group, and not that of an acetal. Similarly to the starting 
material 166, xanthone 168 showed a doublet of doublets at δ 8.25 which was 
assigned to 8-H and showed ortho and meta coupling to 7-H and 6-H, with coupling 
constants J = 8.0 and 1.6 Hz, respectively. A singlet which integrated for one proton 
at δ 7.29 was assigned as 1-H. The 13C NMR spectrum showed a signal at δ 176.0 
which corresponds to the carbonyl group. The signals at δ 155.0 and 154.9 are 
characteristic of carbons single-bonded to oxygen which suggest ether bond 
formation. Strongest confirmation was received from the high resolution mass 
spectrum. The molecular ion was found at m/z 226.0620, and the molecule C14H10O3 
required M+ 226.0630. A crystal structure obtained by Naidoo confirmed the 
xanthone formation. Once again, these results correlated those reported by Naidoo. 
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Scheme 47 
 
It would appear that the xanthone 168 is formed in a similar manner to the dione 
163. CAN oxidation results in the formation of a radical cation 180 or which may 
proceed via the phenoxy oxygen radical 181. This radical cation then cyclises by 
nucleophilic addition of the phenol to radical 182. The radical formed 182 then 
undergoes the elimination of a methoxy radical which results in the re-formation of 
the aromatic ring to give the observed product, xanthone 168. Presumably in this 
case the lack of an extra aromatic ring, as compared to the naphthalene example, 
results in the major product being the fully aromatic xanthone 168 (Scheme 47). 
 
The structure of the minor product 167 was confirmed by spectroscopic analysis. 
The 1H NMR spectrum showed a singlet which integrated for three protons at δ 3.25 
which is due to the methoxy involved in acetal formation. The 1H NMR spectrum also 
showed a singlet at δ 6.81 which is characteristic of a quinone proton and was 
assigned 1-H. Furthermore, the doublet furthest downfield at δ 7.94 is characteristic 
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of an aromatic proton adjacent to a carbonyl group and was assigned as 8-H. This 
signal appears furthest downfield as it is the most deshielded proton due to the 
electron withdrawing effects of the carbonyl bridge. The 13C NMR spectrum showed 
two signals at δ 185.1 and 180.9 which confirmed that the product contained two 
carbonyl carbons. The presence of the signal at δ 51.5 which is due to a carbon 
bonded to a methoxy carbon confirms that a methoxy group was present in our 
product. Also observed in the 13C NMR spectrum was the presence of a signal at δ 
95.1 which is characteristic of an acetal carbon. 
 
Using the same rationale for the formation of dione 163, it could be concluded that 
dione 167 was formed. Confirmation of the formation of the dione came from the 
high resolution mass spectrum, which showed a molecular ion of m/z 242.0568 
(C14H10O4 requires M+ 242.0579). 
 
Having tested these CAN oxidation reactions on both substrates we wanted to try it 
on other substituted benzene precursors not tried by Naidoo. We therefore used 
1,2,4-trimethoxybenzene 183 in this investigation. We envisaged a similar synthetic 
route as followed for the synthesis of 12a-methoxy-5H-benzo[c]xanthene-5,7(12aH)-
dione (Scheme 48). 
 
 
Scheme 48 
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2.4 Synthesis of xanthone 187 
 
Commercially available 1,2,4-trimethoxybenzene 183 was treated with 1 mole 
equivalent of NBS in DCM which underwent electrophilic substitution to afford the 
known halogenated product, 1-bromo-2,4,5-trimethoxybenzene 184. The desired 
compound 184 was furnished in 89% yield as a peach coloured oil. Halogenation 
occurred exclusively at position 2 of 183, due to the ortho and para electron directing 
properties of the methoxy groups at positions 1 and 5. Halogenation was not 
observed at position 6 due to the size of the bromine group (Scheme 49).  
 
 
 
Scheme 49 Reagents and conditions: (i) NBS, DCM, ∆, 48 h, 89% 
 
The 1H NMR spectrum of 184 was fairly simple, showing only five singlets. The two 
singlets observed at δ 7.03 and 6.56 each integrating for one proton was assigned to 
6-H and 3-H respectively. The remaining three singlets at δ 3.88, 3.86 and 3.83 all 
integrated for three protons and correspond to the methoxy group protons. The 13C 
NMR spectrum showed the presence of four quaternary carbons. The NMR 
spectroscopic results analysed for product 184 compared well with the literature and 
unambiguously confirmed that the product was 1-bromo-2,4,5-trimethoxybenzene 
18480. 
 
Having prepared the starting materials successfully, we were now able to construct 
the required precursor ketone. Lithiation of 1-bromo-2,4,5-trmethoxybenzene 184 
using n-BuLi (1.0 equiv.) followed by the benzoylation of the lithiated species with 
Chapter 2: Results and Discussion 
59 
 
benzyl 2-(benzyloxy)benzoate 157 afforded the benzophenone intermediate, [2-
(benzyloxy)phenyl](2,4,5-trimethoxyphenyl)methanone 185 in 52% yield. However, 
despite having followed all precautions to allow single addition, the product was 
obtained in a moderate yield. No other characteristic product could be identified by 
NMR spectroscopy (Scheme 50). 
 
 
 
Scheme 50 Reagents and conditions: (i) THF, –78 °C, n-BuLi (1.0 equiv.), 45 min, benzyl 2-
(benzyloxy)benzoate, 30 min, 52% 
 
Confirmation that the reaction was successful for the synthesis of 185 was obtained 
from both the 1H and 13C NMR spectra. Characteristic signals in the 1H NMR 
spectrum included a singlet at δ 7.26 which was assigned as 6-H. The high 
resolution mass spectrum of the molecular ion C23H23O5 was found at [M + H]+ 
379.1543. The required mass was calculated to be m/z 379.1545. 
The benzophenenone intermediate 185 then underwent a hydrogenolysis reaction to 
facilitate the removal of the O-benzyl substituent. This was easily achieved by stirring 
185 in methanol with 5% Pd/C under a hydrogen atmosphere at a pressure of 1 atm 
to give the phenol 186 (Scheme 51).  
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Scheme 51 Reagents and conditions: (i) 5% Pd/C, methanol, H2(g), 1 atm, 24 h, 93% 
 
The formation of the phenol 186 was confirmed spectroscopically, using 1H and 13C 
NMR spectra. The most significant change in the spectrum of the starting material 
185 was the formation of a singlet at δ 12.18 which is due to the proton of the phenol 
and is a clear indication of the successful deprotection. Another prominent indication 
is the simplification of the aromatic region as well as the loss of the methylene proton 
signals which occurred at δ 4.96 in the starting material and was absent in the 
product. This change was also observed in the 13C NMR spectrum with the absence 
of the methylene carbon of the benzyl substituent in the product which occurred at δ 
70.0 in the starting material.  
 
With the phenol 186 in hand, a ring-closure using CAN was performed in the hopes 
of forming the dione and/or xanthone as previously observed (Scheme 52). The 
oxidation of the phenol 186 proceeded in the presence of CAN, and afforded 
xanthone 187 in 91% yield as white grains. The identity of the structure was 
immediately confirmed upon analysis of the 1H NMR spectrum. As the first indication, 
the singlet previously obtained for the phenol was now absent. The doublet of 
doublets furthest downfield at δ 8.32 was assigned 8-H due to electron withdrawing 
effects of the carbonyl group. This aromatic proton showed both ortho and meta 
coupling to 7-H and 6-H with coupling constants J = 8.0 and 1.0 Hz respectively. A 
singlet at δ 7.64 was assigned to 1-H and showed no coupling due to its position 
adjacent to the carbonyl group. The doublet at δ 6.88 was assigned as 4-H and 
showed very small para coupling to 1-H with a coupling constant J = 1.0 Hz. The 13C 
NMR spectrum provided further evidence that xanthone 187 was formed, with the 
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disappearance of one of the aromatic methoxy groups and the presence of two 
carbons involved in ether formation at δ 156.0 and 155.4. The data obtained 
compared well with that reported in the literature for the compound80. 
 
 
 
Scheme 52 Reagents and conditions: (i) CAN, H2O/CH3CN/CHCl3, rt, 10 min, 91% 
 
As a result of the success of the preceding transformations, we attempted three 
other related transformations. The same synthetic route was followed to afford a 
phenol on which CAN-mediated oxidations could be performed to achieve the 
xanthone or the xanthone-related product. This is described in the following sections. 
 
2.5 Synthesis of Ester 189 
 
Commercially available 5-chlorosalicyclic acid 190 was treated with 3 equivalents 
each of potassium carbonate and benzyl bromide in DMF at 60 °C, which was found 
to be optimal for the synthesis of the dibenzylated product 189. The desired 
compound 189 was obtained in a yield of 85% (Scheme 53). 
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Scheme 53 Reagents and conditions: (i) K2CO3, benzyl bromide, acetone, 60 °C, 18 h, 85% 
 
Confirmation that the desired product 189 had been formed was evident in the 1H 
NMR spectrum with the appearance of two singlets at δ 5.13 and 5.33 for the 
methylene units of the benzylic groups. The doublet furthest downfield was assigned 
as 6-H, as it is the most deshielded aromatic proton due to the electron withdrawing 
effects of the carbonyl group and the chlorine substituent. This doublet clearly shows 
meta coupling to 4-H, with coupling constant J = 2.7 Hz. The doublet at δ 6.94 was 
assigned 3-H and showed ortho coupling to 4-H, with a coupling constant of J = 8.9 
Hz. The 13C NMR spectrum showed two signals at δ 71.0 and 67.1 which correspond 
to the two methylene carbons. As observed in the 1H NMR spectrum, the signal at δ 
70.5 which appears further downfield was assigned to the ester moiety. Further 
confirmation of the dibenzylated compound is observed in the IR spectrum. The IR 
spectrum showed a strong signal at 1716 cm-1 which is characteristic of carbonyl 
stretching while the absence of a broad signal at around 3300 cm-1 is a clear 
indication that the product 189 is free of hydroxyl groups.  
 
2.6 Synthesis of benzophenones 191, 192 and 193 
 
Having all the starting materials prepared we could now continue with our synthesis 
of related xanthones. The first step in these routes was the formation of the ketones 
191, 192 and 193. The carbonyl bridge was constructed using the same procedure 
used for the preparation of [2-(benzyloxy)phenyl](1,4-dimethoxynaphthalen-2-
yl)methanone 148. This was achieved by lithiation of the brominated aromatic 
compound using n-BuLi (1.0 equiv.) followed by the benzoylation of the lithiated 
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species with benzyl 2-(benzyloxy)-5-chlorobenzoate 189 to produce the 
benzophenone intermediates 191, 192 and 193. These transformations are shown in 
Scheme 54. 
 
 
 
Scheme 54 Reagents and conditions: (i) THF, –78 °C, n-BuLi (1.0 equiv.), 45 min, benzyl 2-
(benzyloxy)benzoate, 30 min, 191 19% (un-optimized), 192 78%, 193 87% 
 
1. Equation A 
 
Purification of benzophenone 191 proved to be difficult. The TLC of the reaction 
mixture showed a number of products. Both normal silica chromatography and flash 
silica chromatography afforded impure products. Recrystallisation, however, yielded 
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pure product, albeit in a low yield. Compound 191, was obtained in an unoptimised 
recrystallised yield of 19% and its structure was confirmed by NMR spectroscopic 
studies.  
 
The 1H NMR spectrum of 191, showed that the formation of the ketone was quite 
evident. The most notable indication is the presence of only one methylene singlet at 
δ 4.86. Furthermore, the 1H NMR spectrum showed a doublet at δ 7.63 and was 
assigned 6’-H, showing meta coupling to 9-H, with a coupling constant of J = 2.6 Hz. 
The 13C NMR spectrum of 191 also confirmed the formation of the ketone, showing a 
signal at δ 194.7 which is characteristic for a carbonyl carbon. Further confirmation 
was the presence of the signal at δ 70.7 which was due to the methylene carbon and 
assigned 7-C. This compound, unlike its precursors, 156 and 189, was a yellow solid 
with a melting point of 160-162 °C. 
 
2. Equation B 
 
The most significant observation in the 1H NMR spectrum of compound 192 is the 
presence of a singlet due to the benzyl methylene protons which occurred at δ 4.91. 
In the 13C NMR spectrum there was a carbonyl peak at δ 193.8 indicative of a 
ketone, as well as a peak at δ 70.5 indicating the methylene carbon of the benzyl 
group. The high resolution mass spectrum of 192 matched the expected value for 
the product (m/z 383.1047).  
 
3. Equation C 
 
The spectroscopic analysis of the product 193 was in line with our expectations and 
thus confirmed the success of the reaction. In the 1H NMR spectrum, the first clear 
indication was the presence of only one methylene signal at δ 4.95, integrating for 
two protons. The aromatic region for the product 193 was similar to that of its 
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precursors 184 and 189. In the 13C NMR spectrum, the presence of a peak at δ 
192.3 was indicative of a ketone carbon. A signal at δ 70.5 indicated the methylene 
carbon of the benzyl group which further confirmed the success of the reaction. The 
high resolution mass spectrum showed a molecular ion at (M++H) 413.1142, 
consistent with the formula C20H22O5Cl (calculated 413.1150) thus confirming the 
formation of the benzophenone intermediate 193.  
 
2.7 Synthesis of phenols 194, 195 and 196 
 
Having successfully constructed the carbonyl bridge in all three required compounds 
as shown in Scheme 54, it was now necessary to remove the benzyl group from 
these compounds. The removal was achieved by subjecting the benzophenone 
intermediates in Scheme 55 to a hydrogenolysis reaction.  
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Scheme 55 Reagents and conditions: (i) 5% Pd/C, EtOAc, H2(g), 1 atm, 24 h, 194 96%, 195 
56%, 196 99% 
 
Having easily removed the benzyl group to furnish the phenol in methanol, we 
attempted the debenzylation of 194 in methanol. Unfortunately, when we attempted 
this methodology, two products were formed for each of the three substrates. The 
reaction was monitored using TLC and it appeared that the O-debenzylation 
occurred but then loss of aromatic chlorine also occurred. This was confirmed by 
spectroscopic analysis of the two products. The solvent in which the reaction was 
performed was then changed to ethyl acetate. A procedure by de Koning and co-
workers was then employed in which they demonstrated debenzylation reactions in 
ethyl acetate81. Ethyl acetate proved to be an excellent solvent to perform the 
hydrogenations in as the aromatic chlorine was still in place once the reaction was 
complete. 
Chapter 2: Results and Discussion 
67 
 
1. Equation A 
 
Compound 191 was subjected to hydrogenation in the presence of palladium on 
carbon as the catalyst in pure ethyl acetate. The removal of the benzyl group 
progressed smoothly and complete conversion to the phenol was obtained after 4 
hours. The product was then purified using standard silica chromatography to afford 
the phenol 194 in 96% yield. The identity of the product was confirmed using 1H and 
13C NMR spectroscopy. The most prominent change in 1H NMR spectrum was the 
disappearance of the signal at δ 4.86 due to the methylene protons as well as a 
simplification of the aromatic region. Another noteworthy change was the 
appearance of a downfield singlet at δ 12.14 which is due to the phenol. The 13C 
NMR spectrum was significantly different in that number of carbons in the aromatic 
region decreased. The upfield region only contains two methoxy signals. The 
absence of the methylene carbon which occurred at δ 4.86 in the 1H NMR spectrum 
was an unmistakable indication that the benzyl group was removed. Analysis of the 
high resolution mass spectrum revealed an observed mass of m/z 341.0581, in good 
agreement with the expected mass of m/z 341.0581 for C19H14O4Cl.  
 
2. Equation B 
 
The removal of the benzyl group from compound 192 was performed in the same 
way as that for compound 191. Once again, the reaction proceeded smoothly and 
complete conversion to the phenol 195 was observed after 4 hours. The product was 
obtained in 56 % yield after purification by column chromatography. Confirmation of 
the structure of the desired product was indicated firstly by the presence of a new 
singlet at δ 11.93 indicative of the phenol, and secondly by the absence of the 
distinctive singlet at δ 4.91, previously indicative of the methylene protons. The most 
noteworthy change in the 13C NMR spectrum was the absence of the methylene 
carbon which occurred at δ 70.5 and was distinctive indication that the benzyl group 
has been removed. The decrease in the number of aromatic carbon signals was also 
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evident. The presence of a broad spectral band at 2931 cm-1 for the hydroxyl group 
in the IR spectrum further confirmed the formation of benzophenone 195.  
 
3. Equation C 
 
Benzophenone 193 was also subjected to reduction using catalytic palladium on 
carbon under a hydrogen atmosphere of 1 atm to produce the phenol 196 in a near 
quantitative yield of 99 % after column chromatography. Again, the most distinctive 
change of the product spectrum was a new singlet at δ 12.04 in the 1H NMR 
spectrum, indicative of the new free phenol substituent. Moreover, the characteristic 
singlet previously occurring at δ 4.95 in the 1H NMR spectrum of the starting material 
was absent. The decrease in the number of aromatic signals in the 13C NMR 
spectrum, as well as the absence of the methylene carbon peak at δ 70.5, further 
attested to the fact that we had removed the benzyl group.  
We were now in a position to attempt the ring closure on our phenol compounds 194, 
195 and 196 using CAN. 
 
2.8 Synthesis of dione 197 
 
Phenol 194 was oxidised by stirring an aqueous acetonitrile/chloroform solution of 
194 in the presence of CAN at room temperature for 24 hours. TLC analysis of the 
reaction mixture showed the formation of only one new product. This result was 
consistent with the unhalogenated dione formation, as observed before (Scheme 
56). 
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Scheme 56 Reagents and conditions: (i) CAN, H2O/CH3CN/CHCl3, rt, 10 min, 93% 
 
Spectroscopic analysis of the compound 197 confirmed that we had once again 
prepared the dione compound. The 1H NMR spectrum showed a singlet at δ 3.02 
which integrated for three protons and which was assigned to the methoxy group. 
Moreover, the absence of the phenol signal at δ 12.14 confirms that the phenol has 
reacted possibly forming the acetal linkage of the dione. The 1H NMR spectrum also 
showed a singlet at δ 7.21 which is characteristic of a quinone proton and is 
assigned 6-H. Further evidence was obtained from the 13C NMR spectrum which 
showed two signals at δ 183.7 and 180.1 which validated that the product contained 
two carbonyl carbons.  
 
2.9 Synthesis of xanthone 198 and dione 199 
 
In the same manner, oxidation of the alcohol 195 was achieved by stirring an 
aqueous acetonitrile solution of 195 in the presence of CAN at room temperature for 
24 hours. TLC analysis of the reaction mixture showed the formation of two new 
product spots, which was expected as this observation was made earlier with the 
formation of 2-methoxyxanthone. The first and major product 198 was 2-chloro-7-
methoxyxanthone, obtained in 63% yield, while the second and minor product 199 
was the expected dione, isolated in a yield of 17% (Scheme 57).  
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Scheme 57 Reagents and conditions: (i) CAN, H2O/CH3CN/CHCl3, rt, 10 min, 198 63%, 199 
17% 
Confirmation of the major product was evident in the 1H NMR spectrum. The first 
indication that the xanthone had formed was the presence of a signal at δ 3.92 
integrating for three protons, which is characteristic for an aromatic methoxy group. 
The position of the methoxy signal was a clear indication that the methoxy was not 
involved in acetal formation. Another feature of the 1H NMR spectrum was the 
presence of a doublet at δ 8.29 which was assigned 1-H and showed meta coupling 
to 3-H with a coupling constant J = 2.6 Hz. A singlet which integrated for one proton 
at δ 7.29 was assigned 1-H. The 13C NMR spectrum showed a signal at δ 176.0 
which corresponds to the carbonyl group. The signals at δ 155.0 and 154.9 are 
characteristic of carbons single bonded to oxygen on an aromatic ring. The mass 
spectrum showed a molecular ion which coincided with the expected mass of m/z 
261.0318.  
 
The 1H and 13C NMR spectra were used to confirm the structure of the minor 
product. As observed in the previous dione products, the 1H NMR spectrum showed 
a singlet, integrating for three protons at δ 3.35 which is due to the methoxy group 
involved in acetal formation due to the upfield nature of this signal. The 1H NMR 
spectrum also showed a doublet at δ 6.89, which is characteristic of a quinone 
proton, and is assigned 1-H, showing meta coupling to 2-H with a coupling constant 
J = 2.0 Hz. Furthermore, the doublet furthest downfield at δ 7.96, which is 
characteristic of an aromatic proton adjacent to a carbonyl group, was assigned as 
6-H and showed meta coupling to 5-H with a coupling constant J = 2.6. This signal 
appears furthest downfield as it is the most deshielded proton due to the electron 
withdrawing effects of the carbonyl bridge and the chlorine substituent. The 13C 
spectrum showed two signals at δ 184.7 and 180.0 which indicated that the 
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compound contained two carbonyl carbons. The upfield methoxy carbon signal at δ 
51.4 further confirmed that the presence of a methoxy group. The absence of the 
hydroxyl peak at 2941 cm-1 in the IR spectrum further confirmed the formation of the 
dione. Additional proof for the formation of the dione was found from the mass 
spectrum which gave a molecular ion m/z 277.0266. The dione 199 required a mass 
m/z 277.0262.  
 
2.10 Synthesis of xanthone 200, dione 201 and spiro compound 202 
 
Our final oxidation reaction of alcohol 196 was once again achieved by stirring an 
aqueous acetonitrile solution of 196 in the presence of CAN at room temperature for 
24 hours (Scheme 58). TLC analysis of the reaction mixture showed the formation of 
three new products after 10 minutes. This result was unexpected as the oxidation of 
186 resulted in only one product which was determined as being the xanthone 187. 
To our surprise the reaction yielded two possible products 200 and 201 as well as an 
unexpected spiro-compound 202. The yields obtained for the expected xanthone 200 
and dione 201 are relatively similar with the dione being the major product. The spiro 
compound 202 was the minor product. Purification of the dione and spiro compound 
proved to be quite time consuming as these compounds had the same Rf values. 
These were separated through several silica gel columns. 
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Scheme 58 Reagents and conditions: (i) CAN, H2O/CH3CN/CHCl3, rt, 10 min, 200 21%, 201 
29%, 202 9%. 
 
Confirmation of the structure of xanthone 200 and dione 201 was easily achieved 
with the major difference between the two being the position of the methoxy group.  
The dione 201 was unambiguously confirmed using the 1H NMR spectrum. The first 
indication that the dione had formed was the presence of two signals at δ 3.92 and 
3.33, each integrating for three protons. The large separation between these two 
signals is a consequence of one of the methoxy groups being tied up in acetal 
formation (the upfield signal) while the other methoxy was not (downfield signal). The 
1H NMR spectrum also showed a singlet at δ 6.87 which integrates for one proton; 
its position is characteristic of that observed for quinone protons and was assigned 
as 1-H. Another singlet at δ 5.94 integrating for one proton was also observed and 
was assigned as 4-H. A doublet furthest upfield at δ 7.96 showed meta coupling with 
a coupling constant of J = 2.6 Hz and was assigned to 8-H. The position of the signal 
was due to the electron withdrawing properties of the adjacent carbonyl group as 
well as the adjacent chlorine substituent. The 13C NMR spectrum showed two 
downfield signals at δ 180.2 and 179.9 which corresponds to the two carbonyl 
groups, the quinone carbonyl and the xanthone carbonyl respectively. Furthermore, 
the signal at δ 98.2 has become the familiar signal for the quaternary carbon central 
to acetal formation. 
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Confirmation of the successful formation of the xanthone 200 was obtained from the 
1H and 13C NMR spectra. The relatively simple spectrum clearly shows a doublet 
furthest downfield at δ 8.27 which shows meta coupling. This signal was assigned 8-
H and showed coupling to 6-H with a coupling constant of J = 2.6 Hz. The next signal 
upfield was a signal at δ 7.62 which integrated for one proton and was assigned 1-H. 
The methoxy groups were located at δ 4.02 and 4.00. The closeness of these signal 
indicated similar environments as well indicating that these methoxy groups are 
bonded to an aromatic ring and not part of an acetal. In the 13C NMR spectrum the 
furthest signal downfield was at δ 174.9 which indicates the presence of a carbonyl 
group. Final confirmation of the xanthone molecule was obtained from the mass 
spectrum which was in line with our expectations showing a molecular ion m/z 
291.0438, which corresponds well with the expected value m/z 291.0424. 
 
The structure of the minor compound from the reaction proved to be difficult to 
confirm. The relatively simply 1H NMR spectrum showed two quinone-type protons 
integrating for one proton each at δ 5.76 and 5.17 and were assigned 3’-H and 6’-H 
respectively. Another feature is the two singlets at δ 3.69 and 3.68 which integrate 
for three protons each and correspond to the methoxy groups. The 13C NMR 
spectrum showed two downfield peaks at δ 194.4 and 181.1 which indicated that the 
compound contained two carbonyl groups. Having scrutinised the spectroscopic 
data, many questions still remained as these proved inconclusive. 
 
However, we were fortunate at this stage to obtain a crystal structure of our product 
(Figure 2), enabling us to unambiguously confirm our structure. Structural features 
worth mentioning are the spirocyclic compound. It is presumed that the oxygen 
substituent in the para position to the newly formed five membered ring facilitates the 
reaction resulting in the spiro compound 202. 
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Figure 2: ORTEP diagram for the crystal structure (5-chloro-2',5'-dimethoxy-3H-
spiro[benzofuran-2,1'-cyclohexa[2,5]diene]-3,4'-dione 202. 
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3 Chapter 3: Conclusions and Future work 
 
3.1 Summary of results achieved 
 
The primary aim of this project was the synthesis of the diones 163 and 188 as well 
as xanthone 187. The dione 163 was successfully synthesised over 4 steps from the 
commercially available salicyclic acid 149 and 1,4-dimethoxynaphthalene 148 
(Scheme 59). The synthesis commenced with the preparation of the starting 
materials 156 and 157. Salicyclic acid 149 was protected using benzyl protecting 
groups to afford benzyl 2-(benzyloxy)benzoate 157 in 94%. In a parallel synthesis, 
1,4-dimethoxynaphthalene 148 was brominated to furnish 2-bromo-1,4-
dimethoxynaphthalene 156 in a yield of 92%. Lithiation of 2-bromo-1,4-
dimethoxynaphthalene 156 followed by the benzoylation of the lithiated species with 
benzyl 2-(benzyloxy)benzoate 157 afforded the benzophenone intermediate 158, in 
84% This product was then subjected hydrogenation to produce the phenol 159 in 
97%. Oxidative cyclisation of the phenol 159 resulted in the formation of the dione 
163 in 72% yield. 
 
 
 
Scheme 59 Reagents and conditions: (i) THF, –78 °C, n-BuLi (1.0 equiv.), 45 min, benzyl 2-
(benzyloxy)benzoate, 30 min, 84%, (ii) 5% Pd/C, methanol, H2(g), 1 atm, 24 h, 97%, (iii) CAN, 
H2O/CH3CN/CHCl3, rt, DCM, ∆, 10 min, 72% 
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Using the same procedure detailed above, xanthone 187 and dione 188 were 
prepared in overall yields of 74% and 15% respectively, from commercially available 
salicylic acid 149 1,4-dimethoxybenzene 169bScheme 60).  
 
 
Scheme 60 
 
The syntheses of diones 163 and 188, and xanthone 187 were successfully 
reproduced and in agreement with the results obtained by Naidoo. 
 
The study was then expanded to test the flexibility and the efficiency of the 
methodology. Substitution patterns of both the aryl and the acid were varied to 
determine the effect CAN mediated oxidations have in the formation of xanthone and 
dione analogues.  
 
We then used 1,2,4-trimethoxybenzene 183 as one of our precursors, thereby 
varying the aryl group. Following the same methodology, xanthone 187 was 
exclusively achieved in 91% (Scheme 61).  
 
 
 
Scheme 61 
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Following the success of these reactions, we then varied the benzoic acid 
functionality with the incorporation of a chlorine substituent onto the 5 position of the 
aromatic ring. We then followed the same synthetic scheme; to yield dione 197 in 
93% from 1,4-dimethoxynaphthalene 148 and 5-chlorosalicyclic acid 190. The 
second transformation furnished xanthone 198 and dione 199 from 1,4-
dimethoxybenzene 169 and 5-chlorosalicyclic acid 190 in yields of 63% and 17% 
respectively (Scheme 62). 
 
 
 
Scheme 62 
 
The final transformation commenced from 5-chlorosalicyclic acid 190 and 1,2,4-
trimethoxybenzene 183 to afford the xanthone 200, dione 201 and the unexpected 
spiro-compound 202, in yields of 21%, 29% and 9% respectively (Scheme 63).  
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Scheme 63 
 
3.2 Future prospects for xanthone synthesis 
 
The results from this research project demonstrate the use of CAN as a key reagent 
in the synthesis of the xanthones, diones and possibly spiro-compounds. Although 
the final product did not always afford the xanthone exclusively, chemical 
transformations could be carried out on the diones as well as the spiro-compound, in 
so doing converting these into xanthone compounds. Scheme 64 shows the 
conversion of diones 188 and 163 to xanthones 203 and 204, respectively when 
subjected to a hydrogen atmosphere in the presence of palladium on carbon as a 
catalyst. Similar transformations were achieved by Franck and Zeidler in their 
transformation of dione 205 to xanthone 206 (Scheme 64)82. 
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Scheme 64 
 
The spiro-compound 202 could also be converted into the xanthone 207 by heating 
under reduced pressure followed by sublimation. This type of transformation was 
demonstrated by de Koning and Giles 68. 
 
 
 
Scheme 65 
With this synthetic procedure in hand, naturally occurring xanthones such as 208 
and 209, which are believed to be biologically active against cancer, malaria as well 
as HIV could be prepared (Scheme 66). 
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Scheme 66 
 
In conclusion, the aims of the project were achieved with a proposal towards the 
mechanism. The synthetic route developed using CAN as a key reagent in the 
oxidative cyclisation step provides an alternative route to the synthesis of complex 
xanthones. This methodology could therefore be extended to the synthesis of 
naturally occurring xanthones, many of which are of biological importance. 
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4 Chapter 4: Experimental Procedures 
 
4.1 General Experimental Procedures 
 
4.1.1 Purification of Solvents and Reagents 
 
All reagents used for reactions and preparative chromatography were distilled. 
Solvents used in reactions were pre-dried over the appropriate drying agents in their 
reagent bottles and then distilled over the appropriate drying mediums under a 
nitrogen atmosphere. Tetrahydrofuran (THF) was pre-dried over sodium wire and 
distilled from sodium metal wire and benzophenone. Dichloromethane, acetonitrile 
and methanol were distilled from calcium hydride. When necessary, solvents were 
stored over activated molecular sieves (4Ǻ) under a nitrogen atmosphere. Reagents 
were obtained from commercial sources and used without further purification or 
purified by standard methods as recommended by Perrin et al.83 
 
4.1.2 Chromatography 
 
Thin layer chromatography (TLC) was performed on aluminium-backed Machery-
Nagel ALUGRAMSil G/UV254 plates pre-coated with 0.25mm silica gel 60 or Aldrich 
TLC plates, silica gel on aluminium.  Machery-Nagel Silica gel 60 (particle size 
0.063-0.200mm) was used as the adsorbent for conventional preparative column 
chromatography. When performing flash chromatography, silica gel of particle size 
0.035 mm to 0.070 mm was used. Mixtures of ethyl acetate and hexane were used 
as the mobile phase. 
 
 
 
Chapter 4: Experimental Procedures 
82 
 
4.1.3 Spectroscopic and physical data 
 
All melting points were obtained on a Reichert hot-stage microscope, and are 
uncorrected. 
  
Infrared spectra were obtained on a Bruker Vector 22 spectrometer. Measurements 
were made by loading the sample directly onto a diamond cell. The signals are 
reported on the wavenumber scale (v/cm-1). 
 
Hydrogen (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra 
were recorded on Bruker Avance-300 at 300.13MHz and 75.47 MHz respectively. All 
spectra were recorded in deuterated chloroform (CDCl3) unless otherwise stated and 
chemical shifts are reported in parts per million downfield from tetramethylsilane for 
1H NMR spectra and relative to the central signal of deuterated chloroform, taken at 
δ 77.00 for 13C NMR spectra. Coupling constants are given in Hertz. 
 
Some high resolution electrospray ionization mass spectra (ESI-FTMS) were 
recorded at the Technical University Dortmund, Germany, using a Thermo LTQ 
Orbitrap (high resolution mass spectrometer from Thermo Electron) coupled to an 
“Accela” HPLC System supplied with a “Hypersil GOLD” column (Thermo Electron). 
Others were recorded at the University of Stellenbosch, South Africa on a Waters 
API Q-TOF Ultima. At the University of the Witwatersrand mass spectra were 
recorded on a Kratos MS 9/50, VG 70E MS or a VG 70 SEQ mass spectrometer.  
 
For X-ray crystallography, intensity data were collected on a Bruker APEX II CCD 
area detector diffractometer with graphite monochromated Mo Kα radiation (50kV, 
30mA) using the APEX 284 data collection software. The collection method involved 
ω-scans of width 0.5° and 512x512 bit data frames. Data reduction was carried out 
using the program SAINT+ and face indexed absorption corrections were made 
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using the program XPREP85. The crystal structure was solved by direct methods 
using SHELXTL86. Non-hydrogen atoms were first refined isotropically followed by 
anisotropic refinement by full matrix least-squares calculations based on F2 using 
SHELXTL. Hydrogen atoms were first located in the difference map then positioned 
geometrically and allowed to ride on their respective parent atoms. Diagrams and 
publication material were generated using SHELXTL, PLATON87 and ORTEP-3.88  
 
4.1.4 Other general procedures 
 
All reactions, unless otherwise stated, were carried out under an inert atmosphere 
and the reaction vessels were dried in an oven. In vacuo refers to the removal of 
solvent under reduced pressure (~20 mm Hg, 45oC) on a rotary evaporator and final 
drying on an oil pump (~1-2 mm Hg) at ambient temperature until constant mass was 
achieved. 
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4.2 Synthesis of 2-bromo-1,4-dimethoxynaphthalene 156 
 
 
 
NBS (3.80 g, 0.0214 moles) was added to the 1,4-dimethoxynaphthalene 148     
(4.00 g, 0.0213 moles) in dry CH2Cl2 (30 ml). The mixture was stirred for 18 h at rt. 
The mixture was washed with an aqueous saturated sodium sulfite solution (25 ml) 
and extracted into CH2Cl2 (3 × 50 ml). The organic layer was dried over MgSO4. The 
solvent was removed in vacuo and then purified using column chromatography (5% 
EtOAc/hexane) to afford the product 156 as white grains (5.30 g, 92%). M.p. 56-
58°C, lit. M.p.75 54-55°C; IR (solid): νmax (cm-1): 1662, 1615, 1576, 1505, 1458, 1440, 
1410; 1H NMR (CDCl3, 300MHz) δ= 8.28–8.19 (m, 1H), 8.08–8.05 (m, 1H), 7.63–
7.48 (m, 2H), 6.91 (s, 1H), 3.97 (s, 3H), 3.98 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 
152.1, 146.7, 128.9, 127.3, 125.5, 122.2, 121.7, 111.8, 107.8, 61.3, 55.7; MS (m/z) 
267.03 (M+, 100%), 269.03 (94). 
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4.3 Synthesis of benzyl (2-benzyloxy)benzoate 157 
 
 
 
2-Hydroxybenzoic acid 149 (5.05 g, 0.0366 moles) was dissolved in dry acetone 
(120 ml). Dry potassium carbonate (15.0 g, 0.109 moles) was added and the mixture 
left stirring at rt for 10 mins. Benzyl bromide (12.9 ml, 0.109 moles) was added to the 
stirring mixture and the solution was heated under reflux for 18 h under a N2 
atmosphere. The cooled reaction mixture was filtered through celite, which was 
washed with dry acetone (3 × 50 ml). The solvent was removed in vacuo and the 
residue dissolved in CH2Cl2 (25 ml). The organic layer was washed consecutively 
with 5% aqueous NaOH (25 ml), brine (20 ml) and distilled water (20 ml). The 
organic layer was dried over MgSO4 and the solvent removed in vacuo. The residue 
was subjected to column chromatography (5%-20% EtOAc/hexane) to afford the 
product 157 as a white crystalline solid (11.01 g, 94%). M.p. 48-50°C, lit. M.p.74 50-
51°C; IR (solid): νmax(cm-1): 1716, 1598, 1580, 1495, 1466; 1H NMR (CDCl3, 
300MHz) δ= 7.85 (dd, J = 7.7, 1.7, 1H), 7.52–7.23 (m, 11H), 6.93–6.99 (m, 2H), 5.33 
(s, 2H), 5.13 (s, 2H); 13C NMR (CDCl3, 75MHz) δ= 166.2, 158.1, 136.5, 136.0, 133.4, 
131.8, 128.4, 128.4, 128.1, 128.0, 127.7, 127.0, 120.6, 120.4, 113.6, 70.5, 66.6; MS 
(m/z) 319.20 (M+, 100%), 320.21 (23). 
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4.4 Synthesis of [2-(benzyloxy)phenyl] (1,4-dimethoxynaphthalen2-yl) 
methanone 158 
 
 
 
2-Bromo-1,4-dimethoxynaphthalene 156 (4.05 g, 0.0152 moles) was dissolved in dry 
THF (20 ml) and stirred at -78°C for 5 mins under an N2 atmosphere. n-Butyl lithium 
(1.2 M, 0.015 moles, 18 ml) was added dropwise at -78°C and the mixture stirred at -
78°C for 45 mins under N2. The lithiated mixture was added dropwise to the benzyl-
2-(benzyloxy) benzoate 157 (4.78 g, 0.0143 moles) in dry THF (20 ml) at -78°C. The 
mixture was stirred then for an additional 30 mins at -78°C under an N2 atmosphere. 
The mixture was quenched with a saturated aqueous solution of NH4Cl (25 ml) at -
78°C and allowed to reach rt. The THF was removed in vacuo and EtOAc (50 ml) 
was added. The organic layer was washed consecutively with water (25 ml) and 
brine (25 ml) and dried over MgSO4. The solvent was removed in vacuo and 
subjected to column chromatography (5%-20% EtOAc/hexane) to afford the product 
158 as pale green plate crystals (5.01 g, 84%). M.p. 105-107°C (methanol); IR 
(solid): νmax(cm-1): 1734, 1633, 1619, 1594, 1508, 1486, 1449, 1408; 1H NMR 
(CDCl3, 300MHz) δ= 8.31–8.20 (m, 1H), 8.13–8.04 (m, 1H), 7.69 (d, J = 7.5, 1H), 
7.61–7.42 (m, 3H), 7.15–6.96 (m, 3H), 6.96–6.84 (m, 2H), 6.88 (s, 1H), 6.78–6.70 
(m, 2H), 4.89 (s, 2H), 3.91 (s, 3H), 3.59 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 196.3, 
157.5, 151.7, 150.3, 135.92, 132.91, 130.7, 130.2, 129.1, 128.8, 128.4, 127.9, 127.5, 
127.2, 126.8, 126.8, 123.1, 122.4, 120.7, 112.3, 103.0, 70.3, 63.6, 55.8; MS (m/z) 
399.11 (M+, 100%), 400.13 (26), 279.17 (24), 229.22 (15); HRMS (m/z) calculated 
for C26H22O4, 398.1518, found 398.1523. 
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4.5 Synthesis of (1,4-dimethoxynaphthalen-2yl)(2-hydroxyphenyl)methanone 
159 
 
 
 
5% Pd/C (0.25 g) was added to (2-(benzyloxy)phenyl)(1,4 dimethoxynaphthalen-2-yl) 
methanone 158 (2.50 g, 6.27 mmoles) in dry MeOH (30 ml). The mixture was stirred 
under a H2 atmosphere at a pressure of 4.5 atms for 24 h. The mixture was filtered 
through celite and washed with CH2Cl2 (3 × 50 ml). The organic layer was dried over 
MgSO4. The solvent was removed in vacuo and column chromatography with a 10% 
EtOAc/hexane afforded the product 159 as pale green needles (1.88 g, 97%). M.p. 
116-118°C (methanol); IR (solid): νmax(cm-1): 2970, 1620, 1604, 1592, 1508, 1486, 
1456, 1410; 1H NMR (CDCl3, 300MHz) δ= 12.25 (s, 1H), 8.36–8.27 (m, 1H), 8.18–
8.14 (m, 1H), 7.69–7.39 (m, 4H), 7.05 (d, J = 8.7, 1H), 6.82–6.72 (m, 1H), 6.68 (s, 
1H), 3.94 (s, 3H), 3.81 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 202.4, 163.1, 151.9, 
147.5, 136.9, 134.2, 128.5, 127.7, 127.4, 127.2, 126.4, 122.7, 122.6, 121.0, 119.1, 
118.1, 102.3, 63.7, 55.8; MS (m/z) 309.18 (M+, 100%), 310.18 (19), 331.17 (4); 
HRMS (m/z) calculated for C19H16O4, 308.1049, found 308.1048.  
Chapter 4: Experimental Procedures 
88 
 
4.6 Synthesis of 12a-methoxy-5H-benzo[c]xanthene-5,7 (12aH)-dione 163 
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CAN (13.3 g, 0.0243 moles) in water (25 ml) was added dropwise to a stirring 
mixture of (1,4-dimethoxynaphthalene-2-yl)(2-hydroxyphenylmethanone 159 (1.50 g, 
4.86 mmoles) in MeCN (25 ml) and CHCl3 (5 ml). The mixture was stirred at rt for 10 
mins. The reaction mixture was filtered through celite and washed with EtOAc (3 × 
25 ml). The organic layer was washed consecutively with a saturated aqueous 
NaHCO3 solution (25 ml), brine (25 ml) and water (25 ml). The organic layer was 
dried over MgSO4. The solvent was removed in vacuo and column chromatography 
with a 5% EtOAc/hexane to afford the product 163 as orange rod crystals (1.02 g, 
72%). M.p. 125-127°C (EtOAc); IR (solid): νmax(cm-1): 1713, 1689, 1667, 1636, 1607, 
1596, 1459; 1H NMR (CDCl3, 300MHz) δ= 8.16 (d, J = 7.8, 1H), 8.07–8.02 (m, 2H), 
7.83–7.57 (m, 3H), 7.24–7.08 (m, 3H), 3.03 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 
184.0, 181.0, 157.8, 143.8, 137.0, 136.6, 133.9, 130.8, 130.6, 130.2, 127.6, 126.9, 
126.5, 123.2, 121.5, 118.6, 96.5, 51.5; MS (m/z) 293.07 (M+, 100%), 294.09 (22); 
HRMS (m/z) calculated for C18H12O4, 292.0736, found 292.0778. 
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4.7 Synthesis of 2-bromo-1,4-dimethoxybenzene 16478 
 
 
 
NBS (6.65 g, 37.3 moles) was added to the 1,4-dimethoxybenzene 169 (5.02 g,   
36.3 mmoles) in dry CH2Cl2 (30 ml). The mixture was stirred for 48 h at reflux. The 
mixture was allowed to cool to rt and washed with a saturated aqueous sodium 
sulfite solution (25 ml). The mixture was extracted with CH2Cl2 (3 × 50 ml) and the 
organic layer was dried over MgSO4. The solvent was removed in vacuo and column 
chromatography with a 5% EtOAc/hexane mixture afforded the product 164 as a 
colourless oil (7.01 g, 89%). IR (solid): νmax(cm-1): 1607, 1575, 1530, 1460, 1436; 1H 
NMR (CDCl3, 300MHz) δ= 7.11 (s, 1H), 6.91–6.74 (m, 2H), 3.82 (s, 3H), 3.74 (s, 
3H); 13C NMR (CDCl3, 75MHz) δ= 154.0, 150.3, 119.0, 113.6, 112.9, 111.9, 56.8, 
55.9; MS (m/z) 217.05 (M+, 100%), 219.13 (94), 220.05 (12). 
. 
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4.8 Synthesis of [2-(benzyloxy)phenyl](2,5-dimethoxyphenyl)methanone 165 
 
 
 
2-Bromo-1,4-dimethoxybenzene 164 (2.51 g, 0.0115 moles) was dissolved in dry 
THF (15 ml) and stirred at -78°C for 5 mins under an N2 atmosphere. n-Butyl lithium 
(1.2 M, 0.0115 moles, 14 ml) was added dropwise at -78°C and the mixture stirred at 
-78°C for 45 mins under N2. The lithiated mixture was added dropwise to the benzyl 
2-(benzyloxy) benzoate 157 (3.72 g, 0.0117 moles) in dry THF (20 ml) at -78°C over 
30 mins. The mixture was stirred for an additional 30 mins at -78°C under N2. The 
mixture was quenched with a saturated solution of NH4Cl (25 ml) at -78°C and 
allowed to reach rt. The THF was removed in vacuo and EtOAc (50 ml) was added. 
The organic layer was washed consecutively with water (25 ml) and brine (25 ml) 
and dried over MgSO4. The solvent was removed in vacuo and column 
chromatography with a 5%-20% EtOAc/hexane mixture afforded the product 165 as 
a light yellow oil (3.22 g, 88%). IR (solid): νmax(cm-1):  1644, 1587, 1491, 1448, 1419; 
1H NMR (CDCl3, 300MHz) δ= 7.59 (dd, J = 7.6, 1.7, 1H), 7.48–7.32 (m, 2H), 7.22–
7.15 (m, 2H), 7.12–7.6.88 (m, 6H), 6.76 (d, J = 7.4, 1H), 4.94 (s, 2H), 3.75 (s, 3H), 
3.52 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 195.4, 157.2, 153.5, 152.8, 136.4, 132.6, 
130.8, 130.4, 130.2, 128.8, 128.4, 127.5, 120.8, 118.5, 114.5, 113.5, 112.3, 70.1, 
56.5, 55.9; MS (m/z) 349.15 (M+, 100%), 350.15 (19), 165.10 (14), 197.13 (12); 
HRMS (m/z) calculated for C22H20O4, 348.1362, found 348.1346. 
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4.9 Synthesis of (2,5-dimethoxyphenyl)(2-hydroxyphenyl)methanone 166 
 
 
 
5% Pd/C (0.05g) was added to (2-(benzyloxy)phenyl)(2,5 
dimethoxyphenyl)methanone 165 (1.00 g, 0.00287 moles) in MeOH (30 ml). The 
mixture was stirred under a H2 atmosphere at a pressure of 4.5 atms for 24 h. The 
mixture was filtered through celite and washed with CH2Cl2 (3 × 50 ml). The organic 
layer was dried over MgSO4. The solvent was removed in vacuo and column 
chromatography with a 10% EtOAc/hexane solution afforded the product 166 as 
white needles (0.66 g, 89%). M.p. 96-98°C (methanol), lit.M.p.79 98-100°C; IR (solid): 
νmax(cm-1): 2941, 1617, 1575, 1481, 1464, 1446, 1420; 1H NMR (CDCl3, 300MHz) δ= 
12.04 (s, 1H) 7.41–7.31 (m, 1H), 7.26 (dd, J = 8.0, 1.5, 1H), 6.96–6.87 (m, 2H), 6.85 
(s, 1H), 6.78–6.55 (m, 2H), 3.67 (s, 3H), 3.60 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 
200.7, 161.8, 152.4, 149.5, 135.5, 132.8, 127.2, 119.0, 117.7, 117.0, 116.0, 112.9, 
111.9, 55.2, 54.7; MS (m/z) 259.14 (M+, 100%), 260.18 (15), 281.11 (5); HRMS (m/z) 
calculated for C15H14O4, 258.0892, found 258.0883. 
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4.10 Synthesis of 4a-methoxy-9H-xanthen-2,9(4aH)-dione 167 and 2-methoxy-
9H-xanthen-9-one 168 
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CAN (1.06 g, 1.94 mmoles) in water (5 ml) was added dropwise to a stirring mixture 
of (2,5 dimethoxyphenyl)(2-hydroxyphenyl)methanone (166) (0.100 g,                 
0.388 mmoles) in MeCN (10 ml) and CHCl3 (2.5 ml). The mixture was then stirred at 
rt for 24 h. The reaction mixture was filtered through celite and washed with EtOAc 
(3 × 25 ml). The organic layer was washed consecutively with a saturated aqueous 
NaHCO3 solution (25 ml), brine (25 ml) and water (25 ml). The organic layer was 
then dried over MgSO4. The solvent was removed in vacuo and column 
chromatography (5% ethyl acetate/hexane) afforded the products 168 and 167 as 
white needles (0.065 g, 74%) and orange grains respectively (0.015 g, 15%). 2-
Methoxy-9H-xanthen-9-one (168). M.p. 131-133°C (EtOAc), lit. M.p.56 134-135°C; IR 
(solid): νmax(cm-1): 1647, 1614, 1488, 1462, 1430; 1H NMR (CDCl3, 300MHz) δ= 8.25 
(dd, J = 8.0, 1.6, 1H), 7.65–7.55 (m, 2H), 7.42–7.31 (dd, J = 7.8, 1.4, 1H), 7.29 (s, 
1H), 7.28–7.14 (m, 2H), 3.83 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 176.0, 155.0, 
154.9, 149.9, 133.5, 125.6, 123.8, 122.7, 121.0, 120.2, 118.4, 116.9, 104.8, 54.9; MS 
(m/z) 227.10 (M+, 100%), 228.10 (12), 249.08 (5); HRMS (m/z) calculated for 
C14H10O3, 226.0630, found 226.0620. 4a-Methoxy-9H-xanthen-2,9(4aH)-dione (167). 
M.p. 110-112°C (EtOAc); IR (solid): νmax(cm-1): 1693, 1669, 1644, 1604, 1577, 1464; 
1H NMR (CDCl3, 300MHz) δ= 7.94 (d, J = 7.8, 1H), 7.53 (t, J = 7.8, 1H), 7.11 (t, J = 
7.5, 1H), 7.03 (d, J = 10.0, 1H), 6.81 (s, 1H), 6.37 (dd, J = 10.4, 1.9, 1H), 3.25 (s, 
3H); 13C NMR (CDCl3, 75MHz) δ= 185.1, 180.9, 157.0, 144.5, 140.1, 137.0, 130.7, 
128.5, 127.5, 123.3, 121.6, 118.5, 95.1, 51.3; MS (m/z) 243.12 (M+, 100%), 244.12 
(15); HRMS (m/z) calculated for C14H10O4, 242.0579, found 242.0568. 
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4.11 Synthesis of 1-bromo-2,4,5-trimethoxybenzene 18480 
 
 
 
In a 100 cm3 RB flask equipped with a reflux condenser, N-bromosuccinimide      
(5.61 g, 30.8 mmol) was added to a clear solution of 1,2,4-trimethoxybenzene 183 
(3.65 ml, 5.18 g, 30.8 mmol) in dry CH2Cl2 (30 ml). The reaction mixture was then 
heated under N2 at reflux for 48 h, during which time a dark brown solution was 
formed. The reaction mixture was then allowed to cool to rt and washed with 
saturated sodium sulfite solution (25 ml). The reaction mixture was extracted into 
CH2Cl2 (3 × 50 ml). The organic extracts were combined and dried with anhydrous 
MgSO4 before filtering through celite. The solvent was then removed in vacuo. The 
residue was purified by silica gel column chromatography (10% EtOAc /Hexane) to 
afford product 184 as a peach coloured oil (8.1 g, 70%). 1H NMR (CDCl3, 300 MHz): 
δ= 7.03 (s, 1H), 6.56 (s, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 3.83 (s, 3H). 
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4.12 Synthesis of [2-(benzyloxy)phenyl](2,4,5-trimethoxyphenyl) methanone 
185 
 
 
 
Following a similar procedure as for the preparation of 158, 1-bromo-2,4,5-
trimethoxybenzene 184 (2.03 g, 8.23 mmol) and 157 (3.440 g, 10.81 mmol) resulted 
in the formation of a yellow solid 185 (2.10 g, 52%) after flash silica gel 
chromatography (10% EtOAc /Hexane). M.p. 97-102°C; IR (solid): νmax(cm-1):1633, 
1597, 1508, 1449, 1434, 1401;  1H NMR (CDCl3, 300 MHz): δ= 7.49 (dd, J=7.5, 1,7, 
1H), 7.42–7.36 (m, 1H), 7.26 (s, 1H), 7.21–7.19 (m, 3H), 7.05–6.93 (m, 4H), 6.33 (m, 
1H), 4.96 (s, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 3.48 (s, 3H); 13C NMR (CDCl3, 75 MHz): 
δ= 194.0, 156.5, 155.1, 153.5, 143.2, 136.6, 132.3, 131.7, 129.5, 128.1, 127.5, 
126.6, 121.5, 120.8, 113.3, 112.1, 97.3, 70.0, 56.6, 56.5, 56.0; HRMS (m/z) 
calculated for C23H23O5 (M + H), 379.1545, found 379.1543.  
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4.13 Synthesis of (2'-hydroxyphenyl)(2,4,5-trimethoxyphenyl)methanone 186  
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Following a similar procedure as for the preparation of 159, (2-
(benzyloxy)phenyl)(2,4,5-trimethoxyphenyl)methanone 185 (1.013 g, 2.677 mmol) 
was stirred under a H2 atmosphere in MeOH (50 ml) with 10% Pd/C (0.0518 g) to 
yield after work-up and silica gel chromatography (20% EtOAc /Hexane) a yellow 
solid 186 (0.7501 g, 93%). mp. 107-110°C; IR (solid): νmax(cm-1): 1613, 1590, 1521, 
1483, 1467, 1439, 1403; 1H NMR (CDCl3, 300 MHz): δ= 12.18 (s, 1H), δ 7.48–7.37 
(m, 2H), 7.01 (d, J = 8.1, 1H), 6.89 (s, 1H,), 6.87–6.75 (m, 1H), 6.60 (s, 1H), 3.97 (s, 
3H), 3.84 (s, 3H), 3.74 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ= 201.0, 162.7, 152.2, 
152.0, 143.1, 136.2, 133.8, 120.3, 118.9, 118.6, 118.0, 112.6, 97.4, 56.5 (× 2), 56.2; 
HRMS (m/z) calculated for C16H17O5 (M + H), 289.1076, found 289.1081.  
 
4.14 Synthesis of 2,3-dimethoxy-9H-xanthen-9-one 187 
 
 
Following a similar procedure as for the preparation of 163 hydroxyphenyl(2,4,5-
trimethoxyphenyl)methanone 186 (269 mg, 0.931 mmol) was treated with CAN 
(2.200 g, 4.013 mmol) to give compound 187 (210 mg, 91%) as white grains after 
flash silica gel chromatography (20% EtOAc /Hexane). M.p. 170-172°C; 1H NMR 
(CDCl3, 300 MHz): δ= 8.32 (dd, J = 8.0, 1.6, 1H), 7.78–7.67 (m, 1H), 7.64 (s, 1H), 
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7.50–7.33 (m, 2H), 6.88 (d, J = 1.0, 1H), 4.00 (s, 3H), 3.99 (s, 3H); 13C NMR (CDCl3, 
75 MHz): δ= 176.0, 156.0, 155.4, 152.4, 146.7, 133.9, 126.5, 123.7, 121.5, 117.6, 
114.9 105.3, 99.6, 56.4, 56.3. 
 
4.15 Synthesis of benzyl-2-(benzyloxy)-5-chlorobenzoate 18989 
 
 
 
In a flask equipped with a reflux condenser, potassium carbonate (8.82 g, 63.8 
mmol) was added to a clear solution of 5-chloro-salicyclic acid 190 (5.007 g,       
29.01 mmol) in dry DMF (120 ml). The resulting mixture was stirred at rt under N2. 
Benzyl bromide (7.59 ml, 10.65 g, 63.82 mmol) was added to the solution using a 
dropping funnel. The reaction mixture was then heated at 60°C for 18 h, during 
which time it became a white paste. The reaction was then cooled, filtered through 
celite and the acetone then removed in vacuo. The residue was dissolved in CH2Cl2 
and was washed consecutively with 5% aqueous NaOH (25 ml), brine (20 ml) and 
distilled water (20 ml). The organic extracts were combined and dried with anhydrous 
MgSO4 before filtering through celite. The solvent was then removed in vacuo. The 
residue was purified by silica gel column chromatography (5-10% EtOAc /Hexane) to 
afford the product, benzyl-2-(benzyloxy)-5-chlorobenzoate 189 as a colorless oil 
which solidified overnight (8.70 g, 85%). M.p. 64-66°C; IR (solid): νmax(cm-1): 1688, 
1600, 1492, 1455, 1411; 1H NMR (CDCl3, 300 MHz): δ= 7.81 (d, J = 2.7, 1H), 7.42–
7.31 (m, 11H), 6.94 (d, J = 8.9, 1H), 5.33 (s, 2H), 5.13 (s, 2H); 13C NMR (CDCl3, 75 
MHz): δ= 165.0, 156.8, 136.2, 135.8, 133.1, 131.6, 128.6, 128.3, 128.0, 127.1, 
125.6, 122.0, 115.2, 71.0, 67.1. 
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4.16 Synthesis of [2'-(benzyloxy)-5'-chlorophenyl](1,4-dimethoxynaphthalen-2-
yl) methanone 191 
 
 
 
Following a similar procedure for the preparation of 159, 2-bromo-1,4-
dimethoxynaphthalene 156 (1.092 g, 1.202 mmol) and 189 (0.854 g, 2.420 mmol) a 
yellow solid precipitated out of solution (241 mg, 19%). The solid was filtered off to 
provide an un-optimized yield of the desired product, (2-(benzyloxy)-5-
chlorophenyl)(1,4-dimethoxynaphthalen-2-yl)methanone 191. M.p. 160-162°C; IR 
(solid): νmax(cm-1): 1637, 1621, 1592, 1489, 1452, 1406;  1H NMR (CDCl3, 300 MHz): 
δ= 8.25 (dd, J = 7.8, 1.4, 1H), 8.06 (dd, J = 7.7, 1.5, 1H), 7.63 (d, J = 2.6, 1H), 7.60–
7.50 (m, 2H), 7.42 (dd, J = 8.8, 2.7, 1H), 7.08–7.03 (m, 1H), 6.96–6.84 (m, 4H), 6.72 
(brd, J = 7.5, 2H), 4.86 (s, 2H), 3.93 (s, 3H), 3.60 (s, 3H); 13C NMR (CDCl3, 75 MHz): 
δ= 194.7, 156.0, 151.9, 150.8, 135.5, 132.2, 129.5, 128.7, 128.3, 128.0, 127.6, 
127.5, 127.0, 126.8, 125.9, 123.1, 122.5, 113.8, 102.7, 70.7, 63.76, 55.80; HRMS 
(m/z) calculated for C26H22O4Cl (M + H), 433.1207, found 433.1217. 
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4.17 Synthesis of (5-chloro-2-hydroxyphenyl)(1,4-dimethoxynaphthalen-2-yl) 
methanone 194 
 
 
 
Following a similar procedure for the preparation of 159, (2-(benzyloxy)-5-
chlorophenyl)(1,4-dimethoxynaphthalen-2-yl)methanone 191 (258mg, 0.597mmol) 
was stirred under a H2 atmosphere in EtOAc (20 ml) with 10% Pd/C (12.9 mg) to 
furnish a pale yellow solid 194 (125 mg, 96%) after flash silica gel chromatography 
(20% EtOAc /Hexane). M.p. 109-111°C IR (solid): νmax(cm-1) 1629, 1614, 1596, 1510, 
1460, 1414; 1H NMR (CDCl3, 300 MHz): δ= δ 12.14 (s, 1H), 8.59–7.99 (m, 2H), 
7.84–7.51 (m, 2H), 7.46–7.41 (m, 2H), 7.02 (d, J = 9.6, 1H), 6.65 (s, 1H), 3.98 (s, 
3H), 3.82 (s, 3H); 13C NMR (CDCl3, 75MHz) δ= 201.6, 161.5, 152.0, 147.8, 136.7, 
132.9, 128.4, 127.9, 127.5, 127.4, 125.7, 123.8, 122.8, 122.7, 120.6, 119.8, 101.9, 
63.9, 55.9; HRMS (m/z) calculated for C19H14O4Cl (M + H), 341.0581, found 
341.0581.  
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4.18 Synthesis of 9-chloro-12a-methoxy-5H-benzo[c]xanthene-5,7(12aH)- dione 
197 
 
 
 
Following a similar procedure as for the preparation of 163 precursor 194 (103.3 mg, 
0.300 mmol) and CAN (0.665 g, 1.212 mmol) in a mixture of CHCl3, H2O and MeCN 
as solvent resulted in the formation of 197 (92 mg, 93%) as a yellow solid after flash 
silica gel chromatography (20% EtOAc /Hexane). M.p. 162-165°C; IR (solid): 
νmax(cm-1): 1726, 1687, 1667, 1633, 1594, 1461, 1419; 1H NMR (CDCl3, 300 MHz): 
δ= 8.16 (dd, J = 7.8, 1.0, 1H), 8.05–7.94 (m, 2H), 7.81 (td, J = 7.7, 1.3, 1H), 7.64 (td, 
J = 7.7, 1.1, 1H), 7.56 (dd, J = 8.8, 2.6, 1H), 7.21 (s, 1H), 7.16 (d, J = 8.8, 1H), 3.02 
(s, 3H); 13C NMR (CDCl3, 75MHz) δ= 183.7, 180.1, 156.2, 143.0, 136.7, 136.2, 
134.0, 131.1, 130.8 130.4, 128.9, 127.0, 126.9, 126.5, 122.4, 120.3, 96.6, 51.4; 
HRMS (m/z) calculated for C18H12O4Cl (M + H), 327.0424, found 327.0413.  
 
4.19 Synthesis of [2'-(benzyloxy)-5'-chlorophenyl](2,5-dimethoxyphenyl) 
methanone 192 
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Compound 164 (2.068 g, 9.528 mmol) and benzyl-2-(benzyloxy)-5-chlorobenzoate 
189 (3.368 g, 9.546 mmol) were treated following a similar procedure as for the 
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preparation of 158. This resulted in the formation of a yellow solid of the product, 
(2(benzyloxy)-5-chlorophenyl)(2,5-dimethoxyphenyl)methanone 192 (2.90 g, 78%) 
after flash silica gel chromatography (20% EtOAc /Hexane). M.p. 170-172°C; IR 
(solid): νmax(cm-1): 1645, 1586, 1494, 1457, 1420; 1H NMR (CDCl3, 300 MHz): δ= 
7.52 (d, J = 2.7, 1H), 7.35 (dd, J = 8.8, 2.7, 1H), 7.21 (m, 3H), 7.11 (d, J = 3.2, 1H), 
6.95 (m, 3H), 6.88 (d, J = 8.8, 1H), 6.76 (d, J = 9.0, 1H), 4.91 (s, 2H), 3.76 (s, 3H), 
3.52 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ= 193.8, 155.6, 153.6, 152.9, 136.0, 131.9, 
129.7, 127.7, 125.9, 119.3, 114.4, 113.7, 113.3, 70.5, 56.3, 55.9; MS (ESI-FTMS) 
(m/z) 383.10 (M+, 100%), 365.09 (10), 282.28 (25), 165.05 (37); HRMS (m/z) 
calculated for C22H20O4Cl (M + H), 383.1050, found 383.1047. 
 
4.20 Synthesis of (5'-chloro-2'-hydroxyphenyl)(2,5-dimethoxyphenyl) 
methanone 195  
 
 
 
(2(Benzyloxy)-5-chlorophenyl)(2,5-dimethoxyphenyl)methanone 192 (1.006 g,    
2.627 mmol) dissolved in EtOAc (40 ml) was treated in a similar manner as for the 
preparation of 159 with 10% Pd/C (100.3 mg) to give compound 195 as a yellow 
solid (0.43 g, 56%) after silica gel chromatography (30% EtOAc /Hexane). M.p. 74-
76°C; IR (solid): νmax(cm-1): 2931, 1632, 1589, 1568, 1491, 1462, 1422; 1H NMR 
(CDCl3, 300 MHz): δ= 11.93 (s, 1H), 7.32 (dd, J = 8.9, 2.6, 1H), 7.22 (d, J = 2.6, 1H), 
6.95 (dd, J = 9.0, 3.0, 1H), 6.88 (m, 2H), 6.76 (d, J = 3.0, 1H) 3.70 (s, 3H), 3.64 (s, 
3H); 13C NMR (CDCl3, 75 MHz): δ= 199.8, 160.3, 152.6, 149.5, 135.3, 131.6 126.5, 
122.4, 119.6, 118.7, 116.6, 112.9, 112.0, 55.2, 54.8; MS (ESI-FTMS) (m/z) 393.05 
(M+ +H, 10%), 282.28 (100), 227.11 (67); HRMS (m/z) calculated for C15H14O4Cl (M 
+ H), 293.0581, found 293.0576.  
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4.21 Synthesis of 2-chloro-7-methoxy-9H-xanthen-9-one 198 and 7-chloro-4a-
methoxy-9H-xanthen-2,9(4aH)-dione 199  
 
 
 
 
(5-Chloro-2-hydroxyphenyl)(2,5-dimethoxyphenyl)methanone 195 (104.4 mg, 0.3567 
mmol) together with CAN (0.9801 g, 1.788 mmol) was treated following a similar 
procedure as for the preparation of 166 to give two products, 198 and 199 after flash 
silica gel chromatography (10% EtOAc /Hexane). The first was the xanthone 198 
which was produced as white needles (53 mg, 63%). M.p. 130-133°C; IR (solid): 
νmax(cm-1): 1655, 1614, 1486, 1461, 1446; 1H NMR (CDCl3, 300 MHz): δ= 8.29 (d, J 
= 2.6, 1H), 7.70–7.59 (m, 2H), 7.46 (d, J = 3.0, 1H), 7.43 (d, J = 3.2, 1H), 7.34 (dd, J 
= 9.2, 3.1, 1H), 3.92 (s, 3H).; 13C NMR (CDCl3, 75 MHz): δ= 176.0, 156.2, 154.4, 
150.9, 134.7, 129.5, 125.9, 125.3, 122.1, 121.8, 119.7, 119.5, 105.8, 56.0; HRMS 
(m/z) calculated for C14H10O3Cl (M + H), 261.0318, found 261.0318. The second was 
the dione 199 which was formed as orange grains (17 mg, 17%). M.p. 122-124°C; IR 
(solid): νmax(cm-1):  1743, 1656, 1616, 1488, 1463, 1447; 1H NMR (CDCl3, 300 MHz): 
δ= 7.97 (d, J = 2.6, 1H), 7.54 (dd, J = 8.8, 2.7, 1H), 7.09 (d, J = 10.4, 1H), 7.07 (d, J 
= 8.8, 1H), 6.89 (d, J = 2.0, 1H), 6.46 (dd, J = 10.4, 2.0, 1H), 3.35 (s, 3H);  13C NMR 
(CDCl3, 75 MHz): δ= 184.7, 180.0, 155.4, 143.8, 139.7, 136.7, 130.9, 129.0, 126.9, 
122.5, 120.2, 95.3, 51.4; HRMS (ESI-FTMS) (m/z) calculated for C14H10O4Cl (M + 
H), 277.0268, found 277.0266. 
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4.22 Synthesis of [2'-(benzyloxy)-5'-chlorophenyl](2,4,5-
trimethoxyphenyl)methanone 193 
 
 
 
1-Bromo-2,4,5-trimethoxybenzene 184 (2.01 g, 8.14 mmol) and benzyl-2-
(benzyloxy)-5-chlorobenzoate 189 (3.76 g, 10.66 mmol) were treated following a 
similar procedure as for the preparation of 158 to furnish (2-(benzyloxy)-5-
chlorophenyl)(2,4,5-trimethoxyphenyl)methanone 193 as a yellow solid (3.80 g, 87%) 
after flash silica gel chromatography (10% EtOAc /Hexane). M.p. 109-111°C; IR 
(solid): νmax(cm-1): 1633, 1599, 1508, 1488, 1451, 1434, 1410; 1H NMR (CDCl3, 300 
MHz): δ= 7.42 (d, J = 2.6, 1H), 7.32 (dd, J = 8.7, 2.7, 1H), 7.28 (s, 1H), 7.25–7.17 
(m, 3H), 7.03–6.93 (m, 2H), 6.87 (d, J = 8.8, 1H), 6.32 (s, 1H), 4.95 (s, 2H), 3.88 (s, 
3H), 3.87 (s, 3H), 3.50 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ= 192.3, 155.4, 154.9, 
154.0, 143.3, 136.2, 134.0, 130.9, 129.0, 128.2, 127.7, 126.5, 125.9, 120.6, 113.5, 
113.0, 96.9, 70.5, 56.5, 56.4, 56.1; MS (ESI-FTMS) (m/z) 413.1142 (M+ +H, 100%); 
HRMS (m/z) calculated for C23H22O5Cl (M + H), 413.1156, found 413.1142. 
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4.23 Synthesis of (5-chloro-2-hydroxyphenyl)(2,4,5-trimethoxyphenyl) 
methanone 196 
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(2-(Benzyloxy)-5-chlorophenyl)(2,4,5-trimethoxyphenyl)methanone 193 (1.008 g, 
2.442 mmol) and 10%Pd/C (50.6 mg) in EtOAc (50 ml) were stirred for 3.5 h under 
an H2 atmosphere following a similar procedure as for the preparation of 159 
resulting in the formation of (5-chloro-2-hydroxyphenyl)(2,4,5-
trimethoxyphenyl)methanone 196 as a yellow solid (0.780 g, 99%) after silica gel 
chromatography (30% EtOAc /Hexane). M.p. 161-163°C; IR (solid): νmax(cm-1): 1625, 
1586, 1511, 1470, 1449, 1435, 1402; 1H NMR (CDCl3, 300 MHz): δ= 12.04 (s, 1H), 
7.41–7.00 (m, 2H), 6.98 (d, J = 9.6, 1H), (s, 1H), 6.60 (s, 1H), 3.99 (s, 3H), 3.86 (s, 
3H), 3.77 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ= 199.9, 161.1, 152.8, 152.2, 143.3, 
135.9, 132.7, 123.2, 121.0, 119.6, 118.2, 112.6, 97.3, 56.5, 56.5, 56.2; MS (ESI-
FTMS) (m/z) 323.07 (M+ +H, 100%), 195.07 (20), 227.11 (6); HRMS (m/z) calculated 
for C16H16O5Cl (M + H), 323.0686, found 323.0680.  
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4.24  Synthesis of 7-chloro-2,3-dimethoxy-9H-xanthene-9-one 200 7-chloro-
3,4a-dimethoxy-2H-xanthene-2,9(4aH)-dione 201 and 5-chloro-2',5'-
dimethoxy-3H-spiro(benzofuran-2,1'-cyclohexa[2,5]diene)-3,4'-dione 202. 
 
 
 
5-Chloro-2-hydroxyphenyl)(2,4,5-trimethoxyphenyl)methanone 196 (1.000 g, 3.117 
mmol) together with CAN (8.486 g, 15.48 mmol) was treated following a similar 
procedure as for the preparation of 159 to afford three products, 200, 201 and 202 
after flash silica gel chromatography (5-10% EtOAc /Hexane). 
7-chloro-2,3-dimethoxy-9H-xanthen-9-one 200 was formed 
as orange needles (185 mg, 21%). M.p.. 202-204°C; IR 
(solid): νmax(cm-1): 1643, 1616, 1562, 1507, 1481, 1460, 
1435; 1H NMR (CDCl3, 300 MHz): δ= 8.27 (d, J = 2.6, 1H), 
7.62–7.58 (m, 2H), 7.39 (d, J = 8.9, 1H), 6.88 (s, 1H), 4.02 (s, 3H), 4.00 (s, 3H); 13C 
NMR (CDCl3, 75 MHz): δ= 174.9, 155.7, 154.3, 152.4, 147.0, 134.0, 129.5, 125.8, 
122.4, 119.4, 114.5, 105.3, 99.6, 56.5, 56.4; HRMS (m/z) calculated for C15H12O4Cl 
(M + H), 291.0424, found 291.0438.  
7-chloro-3,4a-dimethoxy-2H-xanthene-2,9(4aH)-dione 201 
was formed as yellow needles (262 mg, 28%). M.p. 118-
120°C; IR (solid): νmax(cm-1): 1736, 1696, 1674, 1651, 1600, 
1466, 1441, 1421; 1H NMR (CDCl3, 300 MHz): δ= 7.96 (d, J = 
2.6, 1H), 7.53 (dd, J = 8.8, 2.6, 1H), 7.04 (d, J = 8.8, 1H), 6.87 (s, 1H), 5.94 (s, 1H), 
3.82 (s, 3H), 3.33 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ= 180.2, 179.9, 156.0, 152.5, 
144.3, 136.6, 128.1(3), 128.1(1), 126.9, 122.6, 120.1, 106.8, 98.2, 55.7, 51.2; HRMS 
(m/z) calculated for C15H12O5Cl (M + H), 307.0373, found 307.0381. 
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5-chloro-2',5'-dimethoxy-3H-spiro[benzofuran-2,1'-  
cyclohexa[2,5]diene]-3,4'-dione 202 was formed as a light 
brown solid (89 mg, 9%); M.p. 223-225°C IR (solid): 
νmax(cm-1): 1727, 1666, 1614, 1509, 1462; 1H NMR (CDCl3, 
300 MHz): δ= 7.67–7.64 (m, 2H), 7.19 (d, J = 8.5, 0.6, 1H), 5.76 (s, 1H), 5.17 (s, 1H), 
3.69 (s, 3H), 3.68 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ= 194.4, 181.1, 170.8, 167.5, 
153.4, 138.8, 128.3, 124.9, 121.1, 115.1, 104.1, 102.3, 87.0, 56.7, 55.6; HRMS (m/z) 
calculated for C15H12O5Cl (M + H), 307.0373, found 307.0365. 
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A1: Selected 1H and 13C NMR Spectra 
A1.1.1 The 1H NMR Spectrum of compound 163 
 
 
A1.1.2 The 13C NMR Spectrum of compound 163 
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A1.1.3 The 1H NMR Spectrum of compound 168 
 
 
A1.1.4 The 13C NMR Spectrum of compound 168 
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A1.1.5 The 1H NMR Spectrum of compound 167 
 
 
A1.1.6 The 13C NMR Spectrum of compound 167 
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A1.1.7 The 1H NMR Spectrum of compound 187 
 
 
A1.1.8 The 13C NMR Spectrum of compound 187 
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A1.1.9 The 1H NMR Spectrum of compound 197 
 
 
A1.1.10. The 13C NMR Spectrum of compound 197 
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A1.1.11 The 1H NMR Spectrum of compound 198 
 
 
A1.1.12 The 13C NMR Spectrum of compound 198 
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A1.1.13 The 1H NMR Spectrum of compound 199 
 
 
A1.1.14 The 13C NMR Spectrum of compound 199 
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A1.1.15 The 1H NMR Spectrum of compound 200 
 
 
A1.1.16 The 13C NMR Spectrum of compound 200 
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A1.1.17 The 13C NMR Spectrum of compound 201 
 
 
A1.1.18 The 13C NMR Spectrum of compound 201 
 
 
Appendix 
119 
 
A1.1.19 The 1H NMR Spectrum of compound 202 
 
 
A1.1.20 The 13C NMR Spectrum of compound 202 
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A2: Single Crystal Data and Structure for 5-chloro-2',5'-dimethoxy-3H-
spiro[benzofuran-2,1'-cyclohexa[2,5]diene-3,4'dione 202 
 
 
 
 
Table 1.  Crystal data and structure refinement for 202. 
 
Empirical formula  C15 H11 Cl O5 
Formula weight  306.69 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 5.2102(3) Å 
= 90°.  
 b = 30.1686(16) Å 
= 94.569(4)°.  
 c = 8.4028(5) Å 
 = 90°.  
Volume 1316.59(13) Å3 
Z 4 
Density (calculated) 1.547 Mg/m3 
Absorption coefficient 0.310 mm-1 
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F(000) 632 
Crystal size 0.49 x 0.05 x 0.03 mm3 
Theta range for data collection 1.35 to 25.00°. 
Index ranges -6<=h<=6, -35<=k<=35, -9<=l<=9 
Reflections collected 12081 
Independent reflections 2315 [R(int) = 0.0950] 
Completeness to theta = 25.00° 100.0 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2315 / 0 / 192 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0479, wR2 = 0.0886 
R indices (all data) R1 = 0.0927, wR2 = 0.1029 
Largest diff. peak and hole 0.220 and -0.243 e.Å-3 
  
 
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for 202  U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
 
 x y z U(eq) 
 
C(1) 9574(5) 1160(1) 5349(3) 23(1) 
C(2) 11091(6) 1580(1) 6002(3) 24(1) 
C(3) 9603(6) 1957(1) 5348(3) 24(1) 
C(4) 9962(6) 2411(1) 5541(4) 29(1) 
C(5) 8193(6) 2682(1) 4760(4) 31(1) 
C(6) 6073(6) 2517(1) 3807(4) 30(1) 
C(7) 5708(6) 2067(1) 3623(4) 27(1) 
C(8) 7514(6) 1790(1) 4420(3) 23(1) 
C(9) 11253(5) 896(1) 4334(3) 24(1) 
C(10) 12389(5) 519(1) 4846(3) 26(1) 
C(11) 11812(6) 323(1) 6347(3) 24(1) 
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C(12) 9757(6) 535(1) 7227(3) 25(1) 
C(13) 8644(5) 912(1) 6717(3) 24(1) 
C(14) 13130(6) 884(1) 1847(4) 35(1) 
C(15) 7398(6) 487(1) 9506(4) 32(1) 
O(1) 7376(4) 1338(1) 4361(2) 25(1) 
O(2) 13066(4) 1571(1) 6857(2) 34(1) 
O(3) 11568(4) 1108(1) 2949(2) 30(1) 
O(4) 12937(4) -7(1) 6889(2) 37(1) 
O(5) 9251(4) 300(1) 8539(2) 31(1) 
Cl(1) 8512(2) 3254(1) 4965(1) 49(1) 
 
Table 3.   Bond lengths [Å] and angles [°] for 202 
 
C(1)-O(1)  1.462(3)
C(1)-C(13)  1.485(4)
C(1)-C(9)  1.498(4)
C(1)-C(2)  1.571(4)
C(2)-O(2)  1.207(3)
C(2)-C(3)  1.458(4)
C(3)-C(8)  1.383(4)
C(3)-C(4)  1.390(4)
C(4)-C(5)  1.361(4)
C(4)-H(4)  0.9500
C(5)-C(6)  1.404(4)
C(5)-Cl(1)  1.740(3)
C(6)-C(7)  1.379(4)
C(6)-H(6)  0.9500
C(7)-C(8)  1.390(4)
C(7)-H(7)  0.9500
C(8)-O(1)  1.365(3)
C(9)-C(10)  1.338(4)
C(9)-O(3)  1.349(3)
C(10)-C(11)  1.446(4)
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C(10)-H(10)  0.9500
C(11)-O(4)  1.225(3)
C(11)-C(12)  1.492(4)
C(12)-C(13)  1.331(4)
C(12)-O(5)  1.355(3)
C(13)-H(13)  0.9500
C(14)-O(3)  1.448(3)
C(14)-H(14A)  0.9800
C(14)-H(14B)  0.9800
C(14)-H(14C)  0.9800
C(15)-O(5)  1.427(3)
C(15)-H(15A)  0.9800
C(15)-H(15B)  0.9800
C(15)-H(15C)  0.9800
  
O(1)-C(1)-C(13) 109.6(2)
O(1)-C(1)-C(9) 109.8(2)
C(13)-C(1)-C(9) 114.5(2)
O(1)-C(1)-C(2) 104.5(2)
C(13)-C(1)-C(2) 108.8(2)
C(9)-C(1)-C(2) 109.1(2)
O(2)-C(2)-C(3) 130.2(3)
O(2)-C(2)-C(1) 124.7(3)
C(3)-C(2)-C(1) 105.1(2)
C(8)-C(3)-C(4) 121.2(3)
C(8)-C(3)-C(2) 107.4(2)
C(4)-C(3)-C(2) 131.4(3)
C(5)-C(4)-C(3) 117.2(3)
C(5)-C(4)-H(4) 121.4
C(3)-C(4)-H(4) 121.4
C(4)-C(5)-C(6) 122.2(3)
C(4)-C(5)-Cl(1) 119.5(2)
C(6)-C(5)-Cl(1) 118.2(2)
C(7)-C(6)-C(5) 120.6(3)
C(7)-C(6)-H(6) 119.7
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C(5)-C(6)-H(6) 119.7
C(6)-C(7)-C(8) 117.2(3)
C(6)-C(7)-H(7) 121.4
C(8)-C(7)-H(7) 121.4
O(1)-C(8)-C(3) 114.9(2)
O(1)-C(8)-C(7) 123.4(3)
C(3)-C(8)-C(7) 121.6(3)
C(10)-C(9)-O(3) 126.8(3)
C(10)-C(9)-C(1) 122.2(3)
O(3)-C(9)-C(1) 110.9(2)
C(9)-C(10)-C(11) 120.7(3)
C(9)-C(10)-H(10) 119.7
C(11)-C(10)-H(10) 119.7
O(4)-C(11)-C(10) 122.0(3)
O(4)-C(11)-C(12) 120.4(3)
C(10)-C(11)-C(12) 117.6(3)
C(13)-C(12)-O(5) 126.9(3)
C(13)-C(12)-C(11) 121.2(3)
O(5)-C(12)-C(11) 111.9(2)
C(12)-C(13)-C(1) 121.3(3)
C(12)-C(13)-H(13) 119.4
C(1)-C(13)-H(13) 119.4
O(3)-C(14)-H(14A) 109.5
O(3)-C(14)-H(14B) 109.5
H(14A)-C(14)-H(14B) 109.5
O(3)-C(14)-H(14C) 109.5
H(14A)-C(14)-H(14C) 109.5
H(14B)-C(14)-H(14C) 109.5
O(5)-C(15)-H(15A) 109.5
O(5)-C(15)-H(15B) 109.5
H(15A)-C(15)-H(15B) 109.5
O(5)-C(15)-H(15C) 109.5
H(15A)-C(15)-H(15C) 109.5
H(15B)-C(15)-H(15C) 109.5
C(8)-O(1)-C(1) 108.1(2)
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C(9)-O(3)-C(14) 116.4(2)
C(12)-O(5)-C(15) 116.1(2)
Symmetry transformations used to generate equivalent atoms: 
  
Table 4.   Anisotropic displacement parameters (Å2x 103)for 202.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
C(1) 21(2)  22(2) 26(2)  2(1) 0(1)  4(1) 
C(2) 20(2)  28(2) 25(2)  -3(1) 4(2)  -1(2) 
C(3) 23(2)  24(2) 25(2)  2(1) 5(1)  1(1) 
C(4) 31(2)  26(2) 29(2)  0(1) 6(2)  -2(2) 
C(5) 45(2)  16(2) 32(2)  0(1) 8(2)  1(2) 
C(6) 32(2)  29(2) 30(2)  10(1) 6(2)  7(2) 
C(7) 22(2)  27(2) 30(2)  6(1) -3(1)  2(2) 
C(8) 25(2)  21(2) 23(2)  0(1) 7(1)  2(1) 
C(9) 21(2)  26(2) 25(2)  -4(1) 1(1)  0(1) 
C(10) 25(2)  25(2) 28(2)  -2(1) 4(1)  7(2) 
C(11) 24(2)  19(2) 30(2)  -3(1) -2(1)  2(1) 
C(12) 26(2)  23(2) 26(2)  0(1) 2(1)  -2(1) 
C(13) 20(2)  23(2) 30(2)  -1(1) 4(1)  2(1) 
C(14) 35(2)  36(2) 34(2)  -6(2) 7(2)  6(2) 
C(15) 33(2)  30(2) 34(2)  1(2) 8(2)  5(2) 
O(1) 22(1)  19(1) 32(1)  0(1) -4(1)  4(1) 
O(2) 26(1)  33(1) 41(1)  -3(1) -4(1)  0(1) 
O(3) 32(1)  30(1) 27(1)  3(1) 9(1)  9(1) 
O(4) 43(1)  29(1) 40(1)  4(1) 9(1)  13(1) 
O(5) 37(1)  24(1) 33(1)  2(1) 9(1)  7(1) 
Cl(1) 69(1)  22(1) 57(1)  2(1) 0(1)  0(1) 
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Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for 202. 
 
 x  y  z  U(eq) 
H(4) 11381 2527 6189 34 
H(6) 4878 2717 3283 36 
H(7) 4283 1951 2980 32 
H(10) 13588 378 4217 31 
H(13) 7228 1024 7238 29 
H(14A) 14875 842 2351 52 
H(14B) 13203 1063 880 52 
H(14C) 12369 594 1564 52 
H(15A) 7929 788 9824 48 
H(15B) 7278 304 10461 48 
H(15C) 5715 498 8896 48 
 
Table 6.  Torsion angles [°] for 202 
_ 
O(1)-C(1)-C(2)-O(2) -179.0(3) 
C(13)-C(1)-C(2)-O(2) 64.0(4) 
C(9)-C(1)-C(2)-O(2) -61.6(4) 
O(1)-C(1)-C(2)-C(3) 0.8(3) 
C(13)-C(1)-C(2)-C(3) -116.3(2) 
C(9)-C(1)-C(2)-C(3) 118.2(2) 
O(2)-C(2)-C(3)-C(8) 179.1(3) 
C(1)-C(2)-C(3)-C(8) -0.7(3) 
O(2)-C(2)-C(3)-C(4) -1.9(5) 
C(1)-C(2)-C(3)-C(4) 178.3(3) 
C(8)-C(3)-C(4)-C(5) -0.9(4) 
C(2)-C(3)-C(4)-C(5) -179.7(3) 
C(3)-C(4)-C(5)-C(6) 0.5(4) 
C(3)-C(4)-C(5)-Cl(1) 179.4(2) 
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C(4)-C(5)-C(6)-C(7) -0.1(5) 
Cl(1)-C(5)-C(6)-C(7) -179.0(2) 
C(5)-C(6)-C(7)-C(8) 0.1(4) 
C(4)-C(3)-C(8)-O(1) -178.8(3) 
C(2)-C(3)-C(8)-O(1) 0.3(3) 
C(4)-C(3)-C(8)-C(7) 0.9(4) 
C(2)-C(3)-C(8)-C(7) 180.0(3) 
C(6)-C(7)-C(8)-O(1) 179.2(3) 
C(6)-C(7)-C(8)-C(3) -0.5(4) 
O(1)-C(1)-C(9)-C(10) -141.3(3) 
C(13)-C(1)-C(9)-C(10) -17.5(4) 
C(2)-C(1)-C(9)-C(10) 104.7(3) 
O(1)-C(1)-C(9)-O(3) 43.2(3) 
C(13)-C(1)-C(9)-O(3) 166.9(2) 
C(2)-C(1)-C(9)-O(3) -70.8(3) 
O(3)-C(9)-C(10)-C(11) -178.3(3) 
C(1)-C(9)-C(10)-C(11) 6.9(4) 
C(9)-C(10)-C(11)-O(4) -175.5(3) 
C(9)-C(10)-C(11)-C(12) 5.0(4) 
O(4)-C(11)-C(12)-C(13) 175.1(3) 
C(10)-C(11)-C(12)-C(13) -5.5(4) 
O(4)-C(11)-C(12)-O(5) -4.7(4) 
C(10)-C(11)-C(12)-O(5) 174.8(2) 
O(5)-C(12)-C(13)-C(1) 173.6(3) 
C(11)-C(12)-C(13)-C(1) -6.1(4) 
O(1)-C(1)-C(13)-C(12) 140.8(3) 
C(9)-C(1)-C(13)-C(12) 16.9(4) 
C(2)-C(1)-C(13)-C(12) -105.5(3) 
C(3)-C(8)-O(1)-C(1) 0.3(3) 
C(7)-C(8)-O(1)-C(1) -179.4(3) 
C(13)-C(1)-O(1)-C(8) 115.9(2) 
C(9)-C(1)-O(1)-C(8) -117.6(2) 
C(2)-C(1)-O(1)-C(8) -0.7(3) 
C(10)-C(9)-O(3)-C(14) 5.5(4) 
C(1)-C(9)-O(3)-C(14) -179.2(2) 
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C(13)-C(12)-O(5)-C(15) -2.7(4) 
C(11)-C(12)-O(5)-C(15) 177.0(2) 
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